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Introduction: Biological Warfare 
and Bioterrorism Agents
In recent years, the possibility of biological warfare and bio-
terrorism has become of increasing concern to both military 
planners and civil defense authorities. The mailing of anthrax 
spore containing letters to destinations within the United States 
in 2001 brought the sudden realization that bioterrorism is not 
merely a theoretical threat but a real and present danger. Since 
then, much thought and planning has gone into defining possible 
biowarfare and bioterrorism agents. There are six requirements 
for these agents that are relevant here:
1) A high degree of morbidity and lethality.
2) Highly infectious microbes or highly toxic substances.
3) Easy to distribute widely in an active form.
4) Easy to produce in bulk and store until delivered.
5) Reasonably hardy in the environment after distribution.
6) Bacteria should be genetically engineered to be resistant to 
known antibiotic drugs.
The 2001 bioterrorist attacks in the US using anthrax spores 
and the US Postal Service as the spreading medium have once 
more emphasized the need of early detection and decontami-
nation of critical facilities in the shortest possible time. During 
the recent decade there has been a remarkable progress in the 
detection, protection, and decontamination of biological war-
fare agents since various and sophisticated detection/decon-
tamination methods have been developed and implemented. 
Nevertheless the threat of biological warfare agents and their 
possible use in bioterrorist attacks still remains a leading cause 
of concern in the global community. Furthermore, in the past 
decade there have been threats to the global society due to the 
emergence of new infectious diseases and/or re-emergence of 
old infectious diseases that were considered eliminated. Adding 
to the milieu the observed global rise in the antimicrobial resis-
tance, the preparedness of societies against these agents becomes 
obvious. Under these circumstances it becomes obvious that the 
field requires better knowledge about the disease agents, more 
research, better training and diagnostic facilities, and improved 
public health system1 (see Table 1).
The emergence of bacterial strains that are resistant to all 
known antibiotics represents a major challenge to human health. 
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Biological warfare and bioterrorism is an unpleasant fact 
of 21st century life. Highly infectious and profoundly virulent 
diseases may be caused in combat personnel or in civilian 
populations by the appropriate dissemination of viruses, bac-
teria, spores, fungi, or toxins. Dissemination may be airborne, 
waterborne, or by contamination of food or surfaces. coun-
termeasures may be directed toward destroying or neutral-
izing the agents outside the body before infection has taken 
place, by destroying the agents once they have entered the 
body before the disease has fully developed, or by immuniz-
ing susceptible populations against the effects. a range of 
light-based technologies may have a role to play in biodefense 
countermeasures. Germicidal uV (uVc) is exceptionally active 
in destroying a wide range of viruses and microbial cells, and 
recent data suggests that uVc has high selectivity over host 
mammalian cells and tissues. Two uVa mediated approaches 
may also have roles to play; one where uVa is combined with 
titanium dioxide nanoparticles in a process called photoca-
talysis, and a second where uVa is combined with psoralens 
(puVa) to produce “killed but metabolically active” microbial 
cells that may be particularly suitable for vaccines. Many micro-
bial cells are surprisingly sensitive to blue light alone, and blue 
light can effectively destroy bacteria, fungi, and Bacillus spores 
and can treat wound infections. The combination of photosen-
sitizing dyes such as porphyrins or phenothiaziniums and red 
light is called photodynamic therapy (pDT) or photoinactiva-
tion, and this approach cannot only kill bacteria, spores, and 
fungi, but also inactivate viruses and toxins. Many reports have 
highlighted the ability of pDT to treat infections and stimulate 
the host immune system. Finally pulsed (femtosecond) high 
power lasers have been used to inactivate pathogens with 
some degree of selectivity. we have pointed to some of the 
ways light-based technology may be used to defeat biological 
warfare in the future.
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One of the most common bacteria, 
Staphylococcus aureus has developed 
resistance to β-lactams (known as 
methicillin-resistant S. aureus or 
MRSA) and its vancomycin-resistant 
counterpart (VRSA) have been iso-
lated form infected patients in vari-
ous parts of the world. Other species, 
such as Streptococcus pyogenes, are 
highly virulent and systemic infection 
can result in death in times as short 
as 48 h. As a consequence, antibiotic-
resistant microorganisms are poten-
tially near-ideal biological weapons 
that could be used either by enemy 
combatants on foreign battlefields or 
by terrorists who have infiltrated the 
country. Antibiotic-resistant, virulent 
strains of common microorganisms 
are particularly attractive as terrorist 
weapons because no security screening 
is in effect for common species. Even 
if detected, the antibiotic-resistant 
nature of the microorganism would 
initially remain hidden and no alarms 
would be raised until large-scale 
contamination and infection had 
occurred. These issues make it imper-
ative that broadly-based alternative 
strategies be developed for the neu-
tralization of drug-resistant biological 
pathogens.
The deliberate creation of pan-
resistant bacterial strains is forbidden 
in laboratories in most Western coun-
tries, but the techniques of genetic 
engineering are relatively well under-
stood and could easily be replicated in 
countries that are rumored to sponsor 
terrorism. Therefore effective counter-
measures against biological weapons 
should be able to deal with multiple 
classes of biological agents regardless 
of whether they have been engineered 
to be resistant to all known antibiotics.
There are many potential bioter-
rorism agents such as bacteria, viruses, 
fungi and toxins that can be spread 
by air, water or food. In this context, 
we emphasize some of these microor-
ganisms due their elevated capabilities 
of being lethally dangerous or easily 
dispersible:
1) In gram-negative bacteria, 
Francisella tularensis causes tularemia 
or rabbit fever, which is debilitating or 
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even fatal.2 Brucella melitensis is also gram-negative and responsi-
ble for the contagious disease of brucellosis in sheep, goats, cattle, 
and in humans causing fever, sweats, anorexia, fatigue, malaise, 
weight loss, and depression.3 A third gram-negative bacterium is 
Yersinia pestis, which infects humans and other animals causing 
plague or “the black death”. This bacterium is primarily a dis-
ease of rodents or other wild mammals that usually is transmitted 
by fleas and often is fatal. Human Yersinia infection takes three 
main forms: pneumonic, septicemia, and bubonic plagues.4 A 
fourth gram-negative species is Burkholderia pseudomallei, which 
causes glanders in animals and melioidosis in humans with a 
mortality rate of 20–50%.5
2) Among the gram-positive bacteria, S. aureus is the most 
well-known bacterium and is frequently found in the human 
respiratory tract and on the skin causing skin infections and 
respiratory diseases beyond promote infections through potent 
protein toxins produced by it. In addition, MRSA is a widespread 
antibiotic-resistant strain and has become a major problem in 
hospitals in the United States.6 S. pyogenes is also a gram-positive 
bacterium that causes invasive and severe infection including sep-
sis and osteomyelitis partly due to its ability to carry out hemoly-
sis releasing hemoglobin.7
3) Bacillus anthracis, Bacillus cereus, and Bacillus thuringi-
ensis are gram-positive bacteria that produce hardy endospores 
that can be easily disseminated. B. cereus is endemic and can be 
transmitted through food while B. thuringiensis produces intra-
cellular protein crystals toxic to a wide number of insect larvae. 
B. anthracis is a rod-shaped bacterium that causes anthrax disease 
and often is lethal. In addition, these bacteria are similar because 
they can produce spores and thus infect larger areas in bioterror-
ism actions.8
4) Viruses such the etiologic agents of Variola, Ebola, and 
Lassa are very dangerous. Variola virus is the etiological agent of 
smallpox, causes 20–30% mortality, and persists in an infectious 
state for many days in dried crusts from skin lesions as well as in 
fluid from vesicles.9 Ebola virus causes severe hemorrhagic fever 
in humans and primates resulting in mortality rates between 
80–90%.9 Lassa virus causes Lassa fever that is endemic in West 
Africa, infecting 2 million people per year and resulting in 5000–
10 000 fatalities annually.9
5) Clostridium botulinum is a gram-positive anaerobic bacte-
rium and produces the most potent known neurotoxin respon-
sible for botulism, which promotes neuromuscular weakness or 
paralysis.10
Historical evidence of the use of biological warfare is some-
what sketchy. In April and May 1979, an unusual anthrax 
epidemic occurred in Sverdlovsk, Union of Soviet Socialist 
Republics. Soviet officials attributed it to consumption of con-
taminated meat but US agencies attributed it to inhalation of 
spores accidentally released at a military microbiology facility in 
the city. Epidemiological data show that most victims worked or 
lived in a narrow zone extending from the military facility to the 
southern city limit. Further south, livestock died of anthrax along 
the extended axis of the zone. The zone paralleled the northerly 
wind that prevailed shortly before the outbreak. It was concluded 
that the escape of an aerosol of anthrax pathogen at the military 
facility caused the outbreak.11
The difficulty faced in decontaminating the environment 
from biological weapons agents can be illustrated by the his-
torical story of Gruinard Island. British military scientists from 
Porton Down in 1942, during the Second World War, had tested 
methods to disseminate anthrax spores on a remote and unin-
habited island off the Scottish coast. Military scientists exploded 
a series of anthrax-spore laden bombs, testing their killing effi-
ciency using sheep.12 Initial efforts to decontaminate the island 
after the biological warfare trials failed due to the high durabil-
ity of anthrax spores. After 44 years of complete quarantine, 
Gruinard Island was finally decontaminated in 1986 with 280 
tons of formaldehyde diluted in seawater being sprayed over all 
196 hectares of the island and the worst-contaminated topsoil 
around the dispersal site being physically removed.13 A flock of 
sheep was then placed on the island and remained healthy.14
In Kosovo, rural villagers reported an unusual massive die-
off of mice and rats in the summer of 1999 in war-devastated 
areas. Clusters and small outbreaks of a human disease with 
fever, lymphadenopathy, and ulcerations of skin and mucosa 
occurred, which were initially diagnosed as tonsillitis until 
tularemia was suspected clinically. Rumors started to circulate 
in some villages that wells had been deliberately contaminated 
with the pathogen. The Albanian authorities asked World Health 
Organization to send in a Global Outbreak Alert and Response 
Network (GOARN) team in order to help in the diagnostics 
and to investigate the origin and cause of this “unusual” tulare-
mia epidemic. Since the strain was thought to be Biovar B (the 
endemic European strain) rather than the more virulent Biovar 
A, the epidemic was attributed to war-related destruction of the 
ecosystem and infrastructure leading to an increased population 
density of rodents and producing human cases of tularemia.15
There have been some documented occurrences of bioterror-
ism. In 1984, two large cohorts of salmonellosis cases (a total 
of 751 individuals) occurred in The Dalles, Oregon. The size 
and nature of this outbreak initiated a criminal investigation. 
The cause only became known when the Federal Bureau of 
Investigation (FBI) investigated a nearby cult (Rajneeshees) for 
other criminal violations. In October 1985, a vial containing a 
culture of Salmonella Typhimurium was discovered by authori-
ties in the Rajneeshee clinic laboratory.16 As gastroenteritis cases 
occurred in increasing numbers, health authorities closed all 
salad bars in The Dalles.
In 1996 between 29 October and 1 November 1996, 12 clini-
cal laboratory workers at the St. Paul Medical Center in Dallas, 
TX developed severe acute diarrheal illness as a result of eating 
muffins and doughnuts left in their break room on 29 October. 
Shigella dysenteriae type 2 was cultured from 8 patients that was 
identical to the laboratory stock strain (some of which was miss-
ing) by pulsed field gel electrophoresis and it was concluded the 
pastries had been deliberately contaminated.17
On 4 October 2001, a case of inhalational anthrax was 
reported in a 63-year-old male in Florida. Authorities initially 
announced this individual had probably contracted the illness 
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by hunting. There were two further 
cases in Florida, and a fourth case 
of cutaneous anthrax was identi-
fied in a female employee at NBC 
news in New York City (NYC). 
Investigators then realized that expo-
sures had occurred from anthrax-
containing letters sent in the mail. 
On 15 October, the Senate Majority 
Leader received an anthrax-contain-
ing letter, which led to the closure 
of the Hart Senate Office Building 
in Washington, DC.18 By the end of 
the year, anthrax-laden letters had 
caused 22 cases of anthrax (10 con-
firmed inhalational and 12 cutane-
ous, of which 7 were confirmed and 5 suspected) and 5 deaths, 
mostly among postal workers and mail handlers.19 A twelfth case 
of cutaneous anthrax occurred in March 2002 in a Texas labora-
tory where the anthrax samples were processed.20
The mode of dispersal of a biological weapons agent may to 
some extent depend on whether the biological agent is being used 
as a form of biological warfare or as bioterrorism. In warfare it 
is more likely that the agent will be dispersed from an aircraft, 
loaded into a bomb or an explosive shell that can be directed 
toward enemy forces, while in bioterrorism it is more likely to be 
surreptitiously released into a subway tunnel or other enclosed 
space, or introduced into the water or food supply, or even sent 
through the mail. Therefore the countermeasures chosen may 
have to take into account widely differing environments that the 
agent may be in.
Countermeasures against biological weapons agents can be 
divided into three broad classes. The first broad class is what can 
be loosely described as disinfectants, or in other words, treat-
ments that can destroy or neutralize the agent in a wide range 
of inorganic, organic, or living environments before the agent 
has had a chance to come into contact with human beings in a 
sufficiently large dose to cause infection of harm. The second 
broad class consists of treatments that can kill or neutralize the 
agent after it has come into contact with human beings, either 
before or after infection or intoxication has become established, 
and this class may include some drugs that can reduce symp-
toms without destroying the agent. The third broad class con-
sists of strategies to vaccinate or immunize people who have been 
exposed to the agent, or who are at risk of exposure, in order to 
avoid infection or to reduce the severity of the consequences of 
exposure.
It is the hypothesis of the present review that light-based 
approaches can be effective in all three of these broad classes of 
countermeasures, and moreover that many of these light-based 
approaches can be effective against all known classes of biologi-
cal weapons agents. We have divided our coverage into sections 
depending on which part of the electromagnetic spectrum is 
being employed (see Fig. 1). These wavelength ranges are: UV 
C (UVC, 220–280 nm); photocatalysis (UVA 320–400 + tita-
nium dioxide); psoralens + UVA (PUVA); blue light (400–470 
nm); photodynamic inactivation (PDI, visible light 400–700-nm 
+ photosensitizers); and near infrared short-pulsed lasers (700–
1400 nm femtosecond). All of the techniques that are listed above 
act as disinfectants to some degree, and can kill or inactivate 
bacteria, fungi, viruses, and toxins in more or less challenging 
environments. Some of them (UVC, blue light, PDI) have been 
shown to be effective in inactivating pathogens without harm-
ing host tissue, after they have come into contact with a subject 
that would otherwise develop an infection, or who already has 
developed an infection. PUVA in particular has been shown to 
be highly effective in inactivating pathogens in such a manner to 
make them good vaccine preparations.
Light has several advantages over alternative disinfectants, 
biocides, and anti-infectives.
• Light is environmentally friendly and non-polluting.
• Light is relatively safe and non-toxic.
• Light does not cause excessive damage to the material sur-
rounding the biological agent, whether inorganic, organic, or 
living.
• Light is relatively cheap to produce.
• Light acts rapidly, usually within seconds.
• Light can be applied to human skin, wounds, mucosa, and 
other sites of exposure without causing undue injury.
• There have been no reports of microbial cells developing 
resistance to light-based anti-infectives.
UV Light and Its Effects over Living Organisms
Light can be classified according to its wavelength and its 
interaction with matter, ionizing or non-ionizing effects. For 
instance, gamma rays (3 × 10−3 nm) have higher energy than 
radio waves (3 × 1013 nm) and as such can promote ionizing 
effects21,22 (see Fig. 1).
Due to its electromagnetic properties, the interaction of 
the light (at all regions of the electromagnetic spectrum) with 
matter leads to triggering of various phenomena. For instance, 
wavelengths less than 100 nm result in changes in the atomic 
charge (ionization) of atoms of the material interacting with 
the photon. However, as the wavelengths increase, the energy 
is not sufficient to produce ionization but can excite electrons 
Figure 1. electromagnetic spectrum and its physiological effects on various microorganisms.
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of this material and elevate them to higher-energy states as 
well as inducing conformational changes in the molecular 
structures21,22
The UV (UV) wavelength region is set between the X-ray 
(≤100 nm) and the visual (>400 nm) bands of the electromag-
netic spectrum. As such, UV light can be classified into four 
wavelengths according to its interaction with molecules: vacuum 
UV (VUV) at 100–200 nm; UV C (UVC) at 200–280 nm; UV 
B (UVB) at 280–315 nm; and UV A (UVA) at 315–400 nm.21-
24 The main physiologic effects, steaming from the photonic 
energy, can be described as:
• VUV light: including wavelengths <200 nm; is harmful due 
to its capability of immediate reaction with oxygen atoms and 
organic molecules even at low doses.
• UVC light: wavelength range lies between 200 and 280 nm; 
this electromagnetic spectrum has biocidal effects and generally 
is reported as “germicidal” or more usually “ultraviolet germi-
cidal irradiation” (UVGI).
• UVB light: comprises wavelengths between 280 to 315 nm; 
these photons are known for “sun burning” of the skin and have 
been implicated in photocarcinogenesis and photoaging.
• UVA light: comprises wavelengths between 315 to 400 nm; 
it is becoming realized that the shorter UVA wavelengths (called 
UVA1, 315–340 nm) can have also have detrimental effects on 
the skin due to production of reactive oxygen species.
Energetically UVC is very important in the context of inac-
tivation of microorganisms, since UVC directly affects deoxyri-
bonucleic acid (DNA) and ribonucleic acid (RNA) by inducing 
molecular transformation (i.e., producing photoproducts in the 
genetic material). The pyrimidines and purines can absorb UV 
light and this way DNA and RNA can be inactivated by UV 
light, especially UVC at 254 nm by oxidation of these bases or 
through base dimerization and formation of cis-syn cyclobutane 
pyrimidine dimmers in the DNA molecules.3,21,22 When DNA is 
damaged it becomes very difficult for the nucleic acids to repli-
cate, and if replication does occur, it often produces a defect that 
prevents the bacterium from being viable.23,25 There are six pos-
sible photoproduct “defects” in the DNA induced by UV light: 
thymine–thymine dimer; cytosine–cytosine dimer; cytosine–
thymine dimer; uracil–uracil dimer; uracil–thymine dimer; and 
uracil–cytosine dimer.21
What are the factors governing the effective photonic interac-
tion with living organisms? The Grotthus–Draper law (first law 
of photochemistry) states that photons must be absorbed for the 
photochemical reaction to occur and the Stark–Einstein law (sec-
ond law of photochemistry) states that, if a photon is absorbed, 
then only one photon should be enough for a photoproduct for-
mation.26 On the other hand, it is well known that microbial 
inactivation is a dose-dependent process (Bunsen–Roscoe reci-
procity law) based on the UV intensity in the irradiation area.21 
UV light (as also applies to all wavelengths) has energy measured 
in joules (J), power in watts (W), area irradiated in cm2 or m2, 
time of irradiation in seconds (s), irradiance (W/area), and flu-
ence or dose (J/area) for calculation of dose-response. In addi-
tion, environmental condition such as humidity, temperature, 
and particle size also affect the dose-response and need to be 
considered, although the duration of exposure required for lethal 
effect of UVC is short.24
UVC light (200 to 280 nm) is the most used light for inac-
tivation of microorganisms.3,9,25,27-35 This inactivation can use 
monochromatic or polychromatic light sources. Indeed, the main 
difference between these UVC lamps is that monochromatic 
lamps such as mercury lamp emitting at 254 nm cause genetic 
damage to microorganism, whereas polychromatic sources with 
other UV regions also affect aromatic proteins (i.e., can also affect 
function and structure of microbial proteins which depends on 
primary, secondary, and tertiary structures).21
UV light sources
The main source of UV light used to kill microorganisms has 
been produced by mercury vapor arc lamps for a long time, pre-
dominately at a wavelength of 253.7 nm (UVC electromagnetic 
spectrum)24 (see Table 2). This kind of lamp is low-pressure mer-
cury (Hg) and are 30% efficient at converting input power to 
UVC at 253.7 nm.36 Currently, and owing to its wider application 
ranges, there is a need for UVC light to be emitted from lamps or 
devices containing non-toxic materials with better efficiency and 
lower costs to make them more affordable, owing to the potential 
risks of mercury lamps being broken and exposing its hazardous 
material to the environment. In this context, light-emitting diode 
(LED) and xenon lamps have gained prominence.36
A UVC LED has been tested in a single-pass flow-through 
device. Unfortunately, the LED is very inefficient at producing 
UVC radiation (0.3%). However, arrays of LEDs can be more 
efficient and produce the expected inactivation.36 The xenon 
lamp emits a peak wavelength at 240 nm. This lamp can have 
a total emission of 10 W of which approximately 1.4 W is UVC 
radiation. This lamp is a non-toxic alternative to mercury but it 
produces ozone, which is a strong oxidant and toxic air pollut-
ant.36 Thus, more research needs to be done in order to improve 
LED efficiency and/or discover others sources of UV light.36
UV light as a viable decontamination technique for poten-
tial biological warfare agents
The first observation how microorganisms respond to light 
was in nineteenth century with experiments using sunlight and 
inactivation or disinfection of test tubes containing Pasteur solu-
tion. At this time it was already known that inactivation or dis-
infection of surfaces was dependent on intensity, duration, and 
wavelength of the light, starting the concept of dose-response. 
Especially in this context, it was observed differences of sensitiv-
ity between different bacteria.23
Since the last century the source of light used to kill micro-
organisms have been the low-pressure mercury (Hg) lamps emit-
ting primarily a short wave (254 nm) of UVC electromagnetic 
spectrum.23 UVC light affects pyrimidines, purines, and flavins 
promoting the formation of dimers in RNA (uracil and cytosine) 
and DNA (thymine and cytosine), which promotes inactivation 
of many microorganisms. Thus, UVC is an established means of 
disinfection and can be used to kill agents causing many infec-
tious diseases.21,23 There have been some studies to determine 
which wavelength in the UVC region is actually best to inacti-
vate microorganisms. Lakretz et al.37 compared UV wavelengths 
between 220 and 280 nm and concluded that 254 and 270 nm 
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Table 2. uV irradiation effect on microorganisms
Microorganism Description UV light Light source Irradiance
Dose and/or time 
of irradiation
Reference
Francisella tularensis petri dishes uVc 254 nm Mercury lamp —— 1.4 mJ/cm2 35
Brucella melitensis/abortus petri dishes uVc 254 nm
Mercury lamp
(5 × 8w)
18.7 mw/cm2 
and 19.5 mw/
cm2
120 to 240 s 34
Staphylococcus aureus infected wounds uVc 254 nm Mercury lamp 2.7 mw/cm2 2.59 J/cm2 (16 min) 25
Methillicin-resistant 
Staphylococcus aureus 
(MRSa)
petri dishes
uV continuous 
(peak at 245 and 
261 nm)
Xenon flash lamp 
(6 w)
250 µw/cm2 1 to 10 s 33
Streptococcus pyogenes petri dishes uVc 265 nm Light-emitting diode 1.93 mw/cm2
1.93 mJ/cm2 (1 s) to
57.95 mJ/cm2 (30 s)
32
Yersinia pestis petri dishes uVc 254 nm Mercury lamp —— ~1.4 mJ/cm2 35
Bacillus anthracis petri dishes uVc 254 nm Mercury lamp —— ~25 mJ/cm2 35
Bacillus cereus petri dishes
uV continuous 
(peak at 245 and 
261 nm)
Xenon flash lamp 
(6 w)
250 µw/cm2 5 to 20 s
33
uV pulsed (53 Hz) 
(peak at 245 and 
261 nm)
Xenon flash lamp 
(6 w)
250 µw/cm2 5 s
Bacillus thuringiensis
air circulation 
system
uVc 254 nm Mercury lamp
1870 µw/cm2 
to 3720 µw/
cm2
30 min to 48 h 31
Bacillus subtilis
petri dishes
white light pulsed 
(250 μs) (200 to 
1100 nm)
Xenon flash lamp ——
0.17 J/cm2 and 
5.28 J/cm2 (1 to 2 min)
30
petri dishes uVc 254 nm Mercury lamp
~1.34 × 10−3 
w/cm2
25 to 1000 mJ/cm2 
(19 s to 12 min)
Bacillus atrophaeus
air circulation 
system
uVc 254 nm Mercury lamp
1870 µw/cm2 
to 3720 µw/
cm2
30 min to 48 h 31
Bacillus megaterium
air circulation 
system
uVc 254 nm Mercury lamp
1870 µw/cm2
to 3720 µw/
cm2
30 min to 48 h 31
Variola virus
airborne 
disinfection 
(hospital)
uVc 254 nm Mercury lamp: 5 w
17 J/m2 to 68 J/m2 
(10 min)
3
ebola petri dishes uVc 254 nm Mercury lamp: 15 w —— 4 J/m2 (0 to 30 s) 9
Lassa petri dishes uVc 254 nm Mercury lamp: 15 w 16 J/m2 (0 to 30 s) 9
Saccharomyces cerivisiae
Fresh nectar from 
fruits
uVc 254 nm Two mercury lamps 25 mw/cm2
75 to 450 kJ/m2 
(15 min at 0.073 and 
1.02 L/min)
29
Trichophyton rubrum
petri dishes uVc 254 nm Germicidal lamp ——
120 mJ/cm2
245
Trichophyton 
mentagrophytes
36–864 J/cm2
ainactivation of 90% (1log10)
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were better at carrying out bacterial inactivation and biofilm 
disruption than 239 and 280 nm. Medium pressure mercury 
lamps emit a wider range of wavelengths than low pressure lamps 
including lines between 365 nm and 578 nm and it has been 
claimed that they are actually better than low pressure lamps at 
inactivating pathogens.38 There have also been studies aimed at 
comparing pulsed with continuous wave (CW) UV light. Using 
365-nm LEDs, Li et al. showed39 that pulsing at 100 Hz was 
superior to CW for inactivating E. coli and C. alibicans biofilms. 
Moreover pulsed xenon light technology (broad spectrum includ-
ing both UV and visible) has also been much studied40 for micro-
bial inactivation.
Due to its killing effects on microorganisms, other applica-
tions of the UVC have been extended into the food processing 
industry, disinfecting heating–cooling coils, ventilating and air-
conditioning systems, whole room/surface disinfection, and into 
killing of all human pathogens (bacterial, viral, and protozoan) 
transmitted via water.21,23,24,36
Considering food-processing, UVC has shown a great poten-
tial for surface disinfection of fresh-cut fruit and vegetables, 
reducing deterioration, prolonging storage life, and becoming 
a viable alternative to chemical sanitizers as titanium dioxide 
(TiO
2
) and chlorine.21 It is important highlight that UV treat-
ment is increasingly common because the process is effective 
against a wide range of microorganisms, overdose is not possible, 
chemical residues or byproducts are avoided, and water quality is 
unaffected and therefore UV treatment has also been an impor-
tant tool for water and wastewater treatments.21
Another significant use of UV light is air disinfection because 
a wide variety of fungal, bacterial, and viral pathogens may be 
transmitted by airborne droplets as e.g., Mycobacterium tubercu-
losis, influenza viruses, SARS corona virus, Aspergillus spp., and 
Legionella spp.21 UV has successfully reduced the concentration 
of airborne microorganisms in operating rooms during surgery. 
The installation of UV light in air handling units and ventilation 
systems reduced the concentration of airborne bacteria and fungi 
in indoor air as well as the total amount of bacteria collected at 
the edge of the surgical site was significantly reduced.21 These 
results foreshadowed the use of UV light in 1935, specifically 
UVC in the ducts of ventilation systems.23
The initial success of air disinfection by UVC in surgical 
rooms stimulated an expansion of UVC application in hospitals. 
For instance, UVC light sources were arranged such that to pro-
vide a kind of “light curtain” and prevent respiratory cross-infec-
tions in infant wards23 and in neonatal intensive care units; UVC 
was used successfully for coil cleaning and promoting signifi-
cantly the reduction of tracheal microbial colonization, as well 
as ventilator-associated pneumonia and the use of antibiotics.36
UVC can be used for whole room disinfection, cleaning the 
air and surfaces under this light. Generally, air disinfection by 
UVC is accomplished through: irradiation on the upper-room 
air; irradiation of the entire room; or irradiation of the air that 
passes through enclosed air-circulation and heating, ventilation, 
and air-conditioning systems.23 For faster results, high-powered 
lamps that generate high fluence levels can be used for whole 
room disinfection, but in unoccupied spaces in order to prevent 
erythema to the skin and photokeratitis in humans36 or when 
people wear specific clothes for their protection.23 Currently in 
the United States, UVC has been installed in air-handling units 
in heating, ventilating, and air conditioning systems to irradiate 
the surfaces of the coil and disinfect system components.36
Although biosafety is a public health concern, most of the 
attention is cornered to hospital environments and microbiology 
laboratories, and bioterrorism concerns have not so far become 
familiar to the public.23,24 However, the technology and methods 
used in health care facilities and laboratories can also help against 
potential bioterrorism agents that cause anthrax, smallpox, viral 
hemorrhagic fevers, pneumonic plague, glanders, tularemia, 
drug-resistant tuberculosis, influenza pandemics, and severe 
acute respiratory syndrome to mention a few.24
Biological UV dosimeters
It is widely accepted that biological UV dosimetry is an indic-
ative tool for assessing the UV radiation impact on health and 
ecosystems. The accumulated data indicates that standard UV 
treatments that are effective against B. subtilis spores are likely 
also to be sufficient to inactivate B. anthracis spores and that 
Table 2. uV irradiation effect on microorganisms
Microorganism Description UV light Light source Irradiance
Dose and/or time 
of irradiation
Reference
Aspergillus fumigates
water disinfection uVc 254 nm Mercury lamp
0.83 mw/cm2 12.45 mJ/cm2
28Aspergillus flavus 0.83 mw/cm2 16.6 mJ/cm2
Aspergillus niger 0.83 mw/cm2 20.75 mJ/cm2
Clostridium botulinum 
toxin
petri dishes uVc 254 nm Germicidal lamp
15 ergs/
mm2 s or 
1.5 µw/mm2
675 to 900 ergs/mm2 
or 67.5 to 90 µJ/mm2
27
ainactivation of 90% (1log10)
(continued)
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the spores of standard B. subtilis strains could reliably be used 
as a biodosimetry model for the UV inactivation of B. anthracis 
spores.41 There are several studies now utilizing the concept of 
“biological UV dosimeters” as indicators of UV exposure where 
bacteria such as E. coli and B. subtilis have been used as sensing 
elements.42
UV radiation is estimated to be one of the most important 
risk factors for nonmelanoma and melanoma skin cancers. In a 
study Moehrle et al.43 assessed the annual occupational UV expo-
sure of mountain guides that were using spore film test chambers 
containing spores of B. subtilis as UV dosimeter-agents that have 
a spectral sensitivity profile similar to erythema-weighted data 
(calculated from spectroradiometric measurements). In the study 
nine mountain guide instructors carried dosimeters on the sides 
of their heads in a total of 1406 working days throughout a year. 
During the study period the dosimeters were changed monthly.43 
In another study by the same group44 they tested the practical 
application of the “biological UV dosimeters” on 11 persons in a 
span of 43 d, under different UV exposure conditions that were 
spread over 5 different geographical regions. The mixed cohort 
included 4 professional lifeguards of a swimming pool who car-
ried the dosimeters attached to their shoulders or to their head-
caps for 11 d; 3 mountain guides that attached the dosimeters 
laterally to their heads on 27 different occasions of mountaineer-
ing activity in different mountain regions; and 4 ski instructors 
who carried lateral head dosimeters during 8 d of skiing in the 
Alps. The conclusion of the study was that B. subtilis spore film 
dosimeters can effectively be used as personal “solar UV exposure 
detectors”.
In a different study Vähävihu et al.45 assessed the viability 
of personal UV dosimeters; where UVB dose exposure during 
a 13-d heliotherapy for atopic dermatitis using B. subtilis spore 
film dosimeters with UV meter, and diary records were used. In 
addition, correlation between personal UVB dose exposure and 
changes in serum 25-hydroxyvitamin D (25[OH]D) was studied 
over a set of 21 adult cohorts in the Canary Islands. The study 
concluded that the increase in serum 25(OH)D correlates with 
the UVB exposure length, and that spore films are feasible and 
reliable in vivo tools to be used as personal UV dosimeters in field 
conditions.45
Bacterial resistance to UV irradiation: effective internal 
repair mechanism
Studies have been revealing that bacterial spores possess an 
enormous resistance to UV radiation46-49 which is a source of 
concern to some degree. Even more interestingly dormant spores 
of the various Bacillus species, including B. subtilis, are shown 
to be 5 to 50 times more resistant to UV radiation than are the 
corresponding growing cells.50-52 This resistance arises largely 
due to the use of a unique DNA repair enzyme called spore 
photoproduct lyase (SP lyase) which apparently repairs specific 
UV-induced DNA lesions through an radical-based mechanism. 
The interesting thing about this repair mechanism is that, unlike 
DNA photolyases, SP lyase belongs to the emerging superfamily 
of radical S-adenosyl-l-methionine (SAM) enzymes and uses a 
(4Fe-4S)+ cluster and SAM to initiate the repair reaction (where 
the DNA lesion recognition and binding site involves a β-hairpin 
structure).46 It has been shown that SAM and the cysteine residue 
are perfectly positioned at the active and as such facilitate the 
hydrogen atom abstraction (from the dihydrothymine residue of 
the lesion) and subsequently donation to the α-thyminyl radical 
moiety. Based on structural and biochemical characterizations of 
mutant proteins, the researchers were able to substantiate the role 
of this cysteine residue in the enzymatic mechanism of action. 
The proposed structure reveals how SP lyase combines specific 
features of radical SAM and DNA repair enzymes, in enabling 
a complex radical-based repair reaction to occur.46 In essence, 
the SP lyase repairs the UV-induced thymine dimmer (a spore 
photoproduct [SP]) in germinating endospores and, as such, it 
is responsible for the strong UV resistance of the endospores. SP 
lyase is a radical S-adenosyl-l-methionine (SAM) enzyme that is 
using the (4Fe-4S)+ cluster in reducing SAM and generating the 
catalytic 5′-deoxyadenosyl radical (5′-dA•).53 A very recent pub-
lication by Young et al. is revealing that two conserved tyrosines 
may be also critical for the enzymes catalytic activity. The one 
tyrosine in B. subtilis SPL, Y99(Bs), is downstream of the cyste-
ine, suggesting that SP lyase uses a novel hydrogen atom transfer 
(HAT) pathway and with a pair of cysteine and tyrosine residues 
regenerates the SAM. The second tyrosine, Y97(Bs), has a struc-
tural role and serves to facilitate the SAM binding. In fact, the 
researchers think that it may also contribute to the SAM regen-
eration process by interacting with the putative Y99(Bs) and/or 
5′-dA intermediates, and thus lowering the energy barrier for the 
second H abstraction step.53
In essence, the observed remarkable resistance of the bacte-
rial spores to chemical and physical stresses, including exposure 
to UV radiation, arises as a result of a unique photochemistry 
of spore DNA that generates and accumulates the spore photo-
product 5-thyminyl-5,6-dihydrothymine and coupled with the 
capabilities of efficient repair of the accumulated damage by the 
enzyme SP lyase this unique viability effect comes to life. As such 
the observed elevated spore UV resistance corner stones can be 
listed as:
• Photochemistry of the DNA within spores: UV generates 
few (if any) cyclobutane dimers, but rather the spore photoprod-
uct 5-thyminyl-5,6-dihydrothymine. As such, it is an exclusive 
DNA photodamage product in bacterial endospores and a radical 
S-adenosylmethionine enzyme (SAM) and the SP lyase (at the 
bacterial early germination phase) repairs it.
• The DNA repair effect (in particular SP lyase repair), dur-
ing spore germination process: the unique UV photochemistry of 
spore DNA is largely due to its saturation with a group of small, 
acid-soluble proteins (SASP) that are unique to spores and whose 
binding alters the DNA conformation and as such its photo-
chemistry. This SP-specific repair is also unique to spores and is 
performed by a light-independent SP-lyase, an iron-sulfur protein 
that utilizes S-adenosylmethionine to catalyze SP monomeriza-
tion without DNA backbone cleavage.47,50,52
Resistance of vegetative bacteria to UV photoinactivation 
can also be developed. The bacterial growth rate strongly affects 
the sensitivity to UVC,54 and bacteria isolated from a high-alti-
tude extreme environment were more resistant to UV.55 There 
are UV-inducible DNA repair systems such as those found in 
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E. coli mutants deficient in induction of mutations by UV light.56 
Nucleotide excision repair involving the products of the uvrA, 
uvrB, and uvrC genes, and the error-prone repair in association 
with the umuDC gene products is also known to occur.57 The lat-
ter process, the SOS response is triggered by the activated RecA* 
protein, which facilitates the autocleavage of the UmuD protein 
to yield the active UmuD9 C-terminal fragment.
Clearly once the potential of UV light to kill microorgan-
isms like bacteria, viruses, and fungi was understood, there has 
been an increasing interest to improve the light utilization. We 
highlight below some studies which used UV light to kill various 
microorganisms in water, air, food, or in experimental models 
and demonstrate that UV light can be a viable tool against a pos-
sible bioterrorist action using these microorganisms.
Germicidal UV for Infections
Although it has been known for the past 100 years that 
UVC irradiation is highly germicidal, the use of UVC irradia-
tion for prevention and treatment of localized infections is still 
in the very early stages of development. Our laboratory has per-
formed several studies designed to show that UVC irradiation 
can be used in vivo to treat mouse models of infections caused 
by virulent and pathogenic microorganisms.58 UVC treatment 
(2.59 J/cm2) of partial thickness skin abrasions in mice infected 
with Pseudomonas aeruginosa increased the survival rate of mice 
by 58.3% (P = 0.0023).25 When the same treatment was applied 
to mice with abrasions infected with S. aureus, the wound heal-
ing rate was increased by 31.2% (P < 0.00001). In mice with 
wounds and burns infected with a virulent strain of Acinetobacter 
baumannii isolated from US soldiers in Iraq, UVC was able to 
reduce the bacterial burden by >90%.59 Although DNA lesions 
were observed by immunofluorescence in the surrounding mouse 
skin immediately after a UVC exposure of 3.24 J/cm2, the lesions 
were extensively repaired within 72 h. UVC was also successfully 
employed to treat a cutaneous Candida albicans fungal infection 
in mouse burns.60
Photocatalytic Inactivation of Biological 
Warfare Agents: Titania Photocatalysis
The ability of titanium dioxide (TiO
2
) to act as a photocata-
lyst has been reported since 192961 (and references therein). In 
1972, Fujishima and Honda62 first reported the photoelectrolysis 
of water at a semiconductor electrode. This property was then 
utilized to catalyze the oxidation of pollutants.63,64 Photocatalytic 
surfaces can be manufactured into construction and building 
materials65 and some of the commercial uses include self-cleaning 
windows and self-cleaning glass covers for road lights61
One of the most important aspects of TiO
2
 photocatalysis 
is that the process, just like the photoelectric effect, depends 
entirely on the energy of the incident photons and not (to a first 
approximation) on their intensity.66 This suggests that, if there 
are even just few photons of required energy, they can induce 
photocatalysis; a phenomenon that has enormous practical 
implications.
There are three main polymorphs of TiO
2
: anatase, rutile, 
and brookite; in all the three forms, titanium (Ti4+) atoms are 
coordinated to 6 oxygen atoms (O2−) and are forming the TiO
6
 
octahedra. Typically TiO
2
 is an n-type semiconductor because of 
its oxygen deficiency, a fact having a leading role in the photocat-
alytic processes and mechanisms. The bandgap energy (energy 
required to promote an electron) of TiO
2
 is of 3.0 eV for the 
rutile, 3.2 eV for anatase, and ~3.2 eV for brookite polymorphs, 
which means that photocatalysis can be activated by photons 
with a wavelength shorter than 385 nm (i.e., UVA). The adsorp-
tion of a photon with sufficient energy promotes an electron 
from the valence band to the conduction band leaving a posi-
tively charged hole in the valence band. The hole may be filled 
by migration of an electron from an adjacent molecule, leaving 
that molecule with a hole, and so on. And when electrons reach 
the surface, they can react with O
2
 to produce superoxide radical 
anion (O
2
•−), and the photogenerated holes can react with water 
to produce hydroxyl radicals (•OH). On the other hand, O
2
•− can 
react further to form H
2
O
2
 and more •OH. As such, the photo-
catalytic process implies photon-assisted generation of catalyti-
cally active ROS rather than an action of the light as a catalyst in 
the reaction (Fig. 2).
The majority of studies have shown that anatase is the most 
effective photocatalyst while rutile is less active. Differences are 
probably due to differences in the extent of recombination of e− 
and hole between the two forms.67 However, studies have shown 
that mixtures of anatase and rutile were more effective photocat-
alysts than 100% anatase and were more efficient for inactivating 
viruses.67
The mechanistic description of the TiO2 photocatalysis pro-
cess can be detailed as follows, where e−
CB
 is the electron gener-
ated at the conduction band, h+
VB
 is the hole generated (and left) 
at the valence band. A recent paper68 suggests that the mecha-
nism could be better characterized as “proton-coupled electron 
transfer”:
TiO
2
 + hv → h+
VB
 + e−
CB
h+
VB
 + e−
CB
 → energy (recombination process)
e−
CB
 + O
2
 → O
2
•− (superoxide radical)
h+
VB
 + H
2
O → H + •OH (hydroxyl radical)
•OH protein/lipid layer → H
2
O + CO
2
O
2
•− + H+ → •OOH (hydroperoxyl radical)
O
2
•− + protein →→ CO
2
 + H
2
O
•OOH + protein/lipid layer → CO
2
 + H
2
O
•OOH + •OOH → O
2
 + H
2
O
2
 (hydrogen peroxide)
H
2
O
2
 + e− → HO− + •OH
One can say that TiO
2
 is a chemically stable and inert material, 
and can continuously exert antimicrobial effects when illumi-
nated. The energy source could be even the solar light; therefore, 
TiO
2
 photocatalysts are also useful in remote areas where elec-
tricity is insufficient. However, because of its large band gap for 
excitation, only biohazardous UV (UV) wavelengths can excite 
TiO
2
, which limits its application in living environments. To cir-
cumvent this problem, impurity doping through metal coating 
and controlled calcination has been successfully used to modify 
the TiO
2
 and to expand its absorption wavelengths to the visible 
light region (discussed below).
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Matsunaga and colleagues69,70 were the first to use TiO
2
 pho-
tocatalysis to kill microorganisms. This subject area has recently 
been comprehensively reviewed71,72 and the effect of key variables 
on the effectiveness has been studied.73
Previous studies have investigated the antibacterial abilities 
of visible light-responsive photocatalysts using the model bac-
teria Escherichia coli and human pathogens. They have shown 
that modified TiO
2
 photocatalysts significantly reduced the 
numbers of surviving bacterial cells in response to visible light 
illumination.
Bacterial inactivation studies have confirmed that even with 
significantly lower levels of TiO
2
 generated radical scavengers, 
i.e., ROS, illumination with far-UV light can successfully pro-
mote microorganisms inactivation.74 Spore-forming bacteria of 
Bacillus strains were investigated for demonstrating photocata-
lytic disinfection effects with relatively good results.75 Armon 
et al. studied the photocatalytic inactivation of spores of B. sub-
tilis and B. cereus (as a model for the main biological warfare 
element B. anthracis76) where the spore-forming B. cereus is 
genetically very closely related to B. anthracis whereas B. subtilis 
is highly resistant to variety of stress factors.77
It has been suggested that the photocatalytic killing mecha-
nism initially damages the weak points at the bacterial cell surface 
before total breakage of the cell membranes. The internal bacte-
rial components then leak from the cells through the damaged 
sites. And finally the photocatalytic reaction oxidizes all of the 
cell debris. In essence, the killing mechanism with TiO
2
 involves 
degradation of the cell wall and cytoplasmic membrane due to 
the production of ROS such as hydroxyl radicals and hydrogen 
peroxide. This initially leads to leakage of cellular contents then 
cell lysis and may be followed by complete mineralization of the 
organism. Killing is most efficient when there is close contact 
between the organisms and the TiO
2
 catalyst71 (Fig. 3).
Huang et al.78 demonstrated with E. coli that TiO
2
-treated 
cells continue to lose their viability even after the UV-irradiation 
stops, indicating that reactions in the media continue to propa-
gate even after the UV-irradiation stops. Once the lethal oxida-
tion reactions are initiated by the TiO
2
 photocatalytic reaction, 
the damaging effects propagate in the dark via the Fenton reac-
tion or free radical chain reactions of lipid peroxidation due to 
ROS.79 The results suggest that initial oxidative damage happens 
on the cell wall (where the TiO
2
 photocatalytic surface makes 
the first contact). The cells that sustained the initial oxidative 
damage insult on their cell walls are still viable, however, though 
localized, elimination of the cell-wall protection makes these 
cells susceptible to ensuing oxidative damages to the underlying 
cytoplasmic membrane. Overall, the photocatalytic action pro-
gressively increases the cell permeability ending in free efflux of 
the intracellular contents, thus, eventually leading to cell death. 
Also, it is plausible that TiO
2
 can gain access into the membrane-
damaged cells and generates a direct insult on the intracellular 
components, thus, accelerating the cell death.80,81
In summary, visible light-responsive TiO
2
 photocatalysts are 
more convenient than the traditional UV light-responsive TiO
2
 
photocatalysts because they do not require harmful UV light 
irradiation to function. These photocatalysts, thus, provide a 
promising and feasible approach for disinfection of pathogenic 
bacteria, facilitating the prevention of infectious diseases.82
By contrast, recombination of the photogenerated charge 
carriers is a major limitation in the use of TiO
2
 as a photo-
catalyst and an initiator in the photocatalytic process, and, as 
such, is an important agent in combating biowarfare. Since 
the excited e− in the recombination process relaxes back to the 
valence band (either non-radiatively or radiatively, dissipating 
its energy as light or heat) without reacting with the possible 
biological sites (and thus not initiating the photocatalytic pro-
cess—a bulk recombination process), there are several strategies 
developed to prevent this from happening and to improve the 
photocatalytic efficiency. To enhance the charge separation of 
the e− and holes and to reduce the likelihood of bulk recombi-
nation, termed photoelectrocatalysis, it is possible to apply an 
electric field.83,84 Other approaches used to achieve improved 
efficiency include either chemical modifications (by incorpo-
rating additional components in the TiO
2
 structure, termed 
as doping) or increasing the surface area and porosity of the 
photocatalyst.85-89
In some cases carbon has been used as a dopant and as such 
allowing not only visible light absorption but also “injecting” 
active trap sites within the TiO
2
 bands, thus increasing the life-
time of the photogenerated charge carriers.85
TiO
2
 can be used in combination with some of the noble 
metals, such as Ag, Au, and Pt, which enhance the photocata-
lytic efficiency under visible light due to “injecting” traps for the 
electrons and promoting the interfacial charge transfer, and thus 
delaying the recombination process of the electron–hole pair.90-94
Data accumulated thus far shows that TiO
2
 exhibits a strong 
visible-light induced anti-microbial activity when modified by 
doping or used in combination. Sulfur-doped TiO
2
 is shown to 
have strong antibacterial effect.95 Carbon-doped TiO
2
 and TiO
2
 
modified with platinum (IV) chloride complexes used as suspen-
sion or immobilized at surfaces (infected with the microorgan-
isms) show remarkable anti-bactericidal effects. The detrimental 
effect of the photocatalysts induced with visible light on various 
microorganism groups such as bacteria (i.e., E. coli, S. aureus, 
Enterococcus faecalis) or fungi (i.e., Aspergillus niger, C. albicans) 
and utilizing modified TiO
2
 showed increased effect over these 
Figure  2. photocatalytic effect of the Tio2: a process where photon-
assisted generation of catalytically active RoS is generated rather than 
an action of the light as a catalyst in the reaction.
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microorganisms in the order: A. niger, C. albicans > E. faecalis, 
S. aureus > E. coli.96
TiO
2
 photocatalysis with UV (UVA) light has proven to be 
a highly effective process for complete inactivation of airborne 
microbes. However, the overall efficiency of the technology needs 
to be improved to make it more attractive as a defense against 
bio-terrorism. Studies investigating the enhancement in the 
rate of destruction of bacterial spores on metal (aluminum) and 
fabric (polyester) substrates with metal (silver)-doped titanium 
dioxide (in comparison with conventional photocatalysis [TiO
2
 
P25/+UVA] and UVA photolysis), where B. cereus bacterial spores 
were used as an index to demonstrate the enhanced disinfection 
efficiency, showed complete inactivation of B. cereus spores with 
the enhanced photocatalyst effectiveness. The enhanced spore 
destruction rate may be attributed to the highly oxidizing radi-
cals generated by the doped TiO
2
.97
According to Wong et al., anion-doped TiO
2
 photocatalytic 
effect is with higher quantum efficiency under sunlight and as 
such showed inactivating effect on both spores and toxins of 
B. anthracis under irradiation by “ordinary” light source such 
as an incandescent lamp. Moreover, these carbon-doped and 
nitrogen-doped TiO
2
 had a better performance in the pres-
ence of silver; the synergistic antibacterial effect resulted in 
approximately 5 logs reduction of E. coli, S. pyogenes, S. aureus, 
and A. baumannii. It appears, the presence of Ag enhances the 
bactericidal properties of various TiO
2
 materials.98 They also 
found that visible light illuminated nitrogen- or carbon-doped 
TiO
2
 significantly reduces the viability of anthrax spores. Even 
though the spore-killing efficiency is 
only approximately 25%, their data 
indicate that spores from photocata-
lyzed groups (not from untreated 
groups) have lower survival rate. In 
addition, their results indicated that 
the photocatalysis could directly 
inactivate a lethal toxin, the major 
virulence factor of B. anthracis. 
The study results show that the 
photocatalyzed spores have 10-fold 
less potency to induce mortality in 
mice in comparison with unexposed 
once. These results suggest that 
photocatalysis might be effective in 
injuring the spores through inacti-
vating some spore components. In 
essence, photocatalysis may be a via-
ble technique in inducing injuries 
to the spores than direct killing in 
order to reduce their pathogenicity 
in the host.99,100
It has been shown that nano-sized 
titania particles exhibit better inacti-
vation properties than the bulk-sized 
titania materials. Sunlight in the 
presence of nano-titania (mixture of 
anatase and rutile phases) displayed 
better photocatalytic bactericidal activity of B. anthracis than sole 
treatment of sunlight.101
Studies on photocatalytic inactivation of spores of B. anthra-
cis have been performed using nano-sized titania materials and 
UVA light or sunlight. Results demonstrated pseudo first order 
behavior of spore inactivation kinetics. The value of kinetic rate 
constant increased from 0.4 h (−1) to 1.4 h (−1) indicating photo-
catalysis facilitated by addition of nano-sized titania. Nano-sized 
titania exhibited superior inactivation kinetics on par with large 
sized titania. The value of kinetic rate constant increased from 
0.02 h (−1) to 0.26 h (−1) on reduction of size from 1000 nm to 
16 nm depicting the enhanced rate of inactivation of B. anthracis 
Sterne spores on the decrease of particle size.102
These results signify that the excited TiO
2
 nanoparticles 
potentiate the antimicrobial action of β lactams, cephalosporins, 
aminoglycosides, glycopeptides, macrolides, and lincosamides, 
making a possible synergistic combination of nano compound 
with antibiotics against MRSA.103
Interestingly, Cheng et al. found that a mixture of anatase/
rutile carbon doped TiO
2
 nanoparticles show significantly 
enhanced bactericidal effect. Their experiments indicated that 
these nanoparticles (with higher bacterial interaction property), 
have significantly higher proportion of bacteria-killing effect over 
all tested pathogens (including S. aureus, Shigella flexneri, and 
A. baumannii). These findings suggest that developing materials 
with high bacterial interaction ability might be a useful strategy 
to improve the antimicrobial activity of visible-light-activated 
TiO
2
.104
Figure 3. photocatalytic killing mechanism initially damages the weak points at the bacterial cells sur-
faces, and then total breakage of the cell membranes ensues, followed by of the internal bacterial com-
ponents through the damaged sites. Finally, the photocatalytic reaction oxidizes all of the cell debris.
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In recent decades, incidences with antibiotic-resistant bacteria 
have shown sharp elevations, and as such, became one of the most 
significant problems in public health. TiO
2
 has the potential to 
inactivate antibiotic-resistant bacteria. In the Tsai et al. study, 
UVA-activated TiO
2
 was successfully used to inactivate the anti-
biotic-resistant bacteria MRSA, multidrug-resistant A. bauman-
nii (MDRAB), and vancomycin-resistant E. faecalis (VRE) in 
suspension. Their results indicated that TiO
2
 reaction time had 
the greatest influence on microbial survival, following the TiO
2
 
exposure in the presence of UVA. TiO
2
 in the presence of UVA 
effectively reduced the number of antibiotic-resistant microbes in 
suspension by 1–3 logs.105
Photo-activated TiO
2
 is effective on microorganisms capable 
of killing a wide range of gram-negative and gram-positive bac-
teria, fungi (both unicellular and filamentous), protozoa, algae, 
mammalian viruses, and bacteriophages; the killing activity is 
enhanced by the presence of other antimicrobial agents, such as 
Cu and Ag.71
The level of UVA disinfection of B. anthracis and B. brevis 
vegetative cells increased with the presence of the TiO
2
 and Ag 
photocatalysts, but had little effect on their spores. Bacillus bre-
vis spores were slightly more sensitive to UVB and UVC than 
the spores of Bacillus atrophaeus. Photocatalytic sterilization 
against spores was strongest in UVC and UVB and weakest in 
UVA. The rate of inactivation of Bacillus spores was significantly 
increased by the presence of TiO
2
 but was not markedly differ-
ent from that induced by the presence of Ag. Therefore, TiO
2
/
Ag plus UVA can be used for the sterilization of vegetative cells, 
while TiO
2
 and UVC are effective against spores.106 However, in 
a study investigating the effects of toxin- and capsule-encoding 
plasmids on the kinetics of UV inactivation of various strains 
of B. anthracis it was found that the plasmids pXO1 and pXO2 
had no effect on bacterial UV sensitivity or photoreactivation. 
Interestingly enough, vegetative cells were capable of photoreac-
tivation whereas photo-induced repair of UV damage was absent 
in B. anthracis Sterne spores107 which shows that B. anthracis 
makes highly stable and heat-resistant spores that can remain 
viable for decades.108
Psoralens and UVA
Psoralens are a group of natural furanocoumarins, com-
mercially derived from a plant found in Egypt, Ammi majus. 
They are also present in celery, carrots, parsley, parsnip, and 
other vegetables. It has been known since ancient times that 
consumption of these foodstuffs followed by sun exposure can 
lead to a phototoxic skin reaction similar to sunburn. The com-
bination of psoralen with UVA light (known as PUVA) was first 
introduced as a medical treatment for psoriasis.109 Patients orally 
ingested psoralen compounds or alternatively the psoralens were 
applied topically in a bath.110 The mechanism is that the pso-
ralen molecule has the correct structure and shape to be able 
to intercalate between the two strands of DNA in the double 
helix, and upon illumination, induce the formation of covalent 
inter-strand cross-linking between opposite nucleic acid strands 
(Fig. 4).
Due to the DNA damaging action PUVA it has been used 
for the inactivation of bacteria, viruses, and protozoa in platelet 
and plasma blood component.111 This photochemical inactiva-
tion using PUVA has the potential even to produce a new class of 
vaccines from whole microbes termed “Killed But Metabolically 
Active” (KBMA). KBMA vaccines are based on whole microbes 
that have been inactivated by defined genotoxic methods that 
leave the organism incapable of productive growth and of causing 
disease but preserve metabolic activity sufficient to induce immu-
nity. These vaccines have two broad applications. First, recom-
binant KBMA vaccines encoding selected antigens relevant to 
infectious disease can be used to elicit a desired immune response. 
And when derived from attenuated forms of a targeted pathogen 
the entire antigenic repertoire is presented to the immune system, 
as here correlate of protection are unknown. In both applications 
the vaccine is inactivated by a distinct and limited disruption 
of the vaccine chromosome using photochemical treatment with 
a psoralen cross-linking agent, impacting an absolute block to 
DNA replication and possible vaccine outgrowth.112 Initially this 
technology was developed for killing undetected microbes con-
taminating plasma and platelet blood products.113,114
Brockstedt et al. performed a landmark study in KBMA vac-
cine approach demonstrating proof of concept for recombinant 
KBMA Lm vaccines in animal models of infectious disease 
and cancer.115 KMBA were developed by removing the genes 
required for nucleotide excision repair (uvrAB) and rendering 
microbial-based vaccines sensitive to photochemical inactivation 
with PUVA. Colony formation of these mutants was blocked by 
infrequent, randomly distributed psoralen crosslinks, though the 
bacterial population was able to express its genes, synthesize, and 
secrete proteins. Using the intracellular pathogen Listeria mono-
cytogenes as a model platform, recombinant psoralen-inactivated 
Lm ΔuvrAB vaccines induced potent CD4+ and CD8+ T-cell 
responses and protected mice against virus challenge in an infec-
tious disease model and provided therapeutic benefit in a mouse 
cancer model. Microbial KBMA vaccines used either as a recom-
binant vaccine platform or as a modified form of the pathogen 
itself may have broad application for the treatment of infectious 
disease and cancer. This was a new vaccine paradigm for eliciting 
effector T-cell responses and protective immunity.
In one study116 KMBA B. anthracis vaccines induced a broad 
and protective immunity against anthrax. In this approach a 
novel whole-bacterial-cell anthrax vaccine utilizing B. anthra-
cis that was KBMA. Vaccine strains that are asporogenic and 
nucleotide excision repair deficient were engineered, rendering 
B. anthracis extremely sensitive to photochemical inactivation 
with amatosalen (S-59) psoralen (Fig. 5A) and UVA light. The 
workers also introduced point mutations, which allowed inactive 
but immunogenic toxins to be produced. These photochemically 
inactivated vaccine strains maintained a high degree of metabolic 
activity and secreted protective antigen, lethal factor, and edema 
factor. KBMA B. anthracis vaccines were found to be avirulent in 
mice and induced less injection site inflammation than recom-
binant protective antigen adsorbed to aluminum hydroxide gel. 
In animals KBMA B. anthracis vaccination produced antibod-
ies against numerous anthrax antigens, including high levels of 
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anti- protective antigen and toxin-neutralizing antibodies and 
fully protected mice against challenge with lethal doses of tox-
inogenic unencapsulated Sterne 7702 spores and rabbits against 
challenge with lethal pneumonic doses of fully virulent Ames 
strain spores. Guinea pigs vaccinated with KBMA B. anthracis 
were partially protected against lethal Ames spore challenge, 
which was comparable to vaccination with the licensed vaccine 
anthrax vaccine adsorbed. Their data demonstrated that KBMA 
anthrax vaccines are well tolerated and elicit potent protective 
immune responses. The use of KBMA vaccines may be broadly 
applicable to bacterial pathogens, especially those for which the 
correlates of protective immunity are unknown.116 Toward the 
development of a KBMA B. anthracis vaccine candidate strain, 
in a different study a plasmid pMAD and a recombinase system 
Cre-loxP were used to knockout the uvrAB gene of B. anthracis 
AP422, which lacks both of two plasmids pXO1 and pXO2. The 
results showed that the constructed B. anthracis AP422ΔuvrAB 
was inactivated by photochemical treatment (including an 
exposure in a long-wavelength UVA light and a treatment of 
8-Methoxypsoralen [8-MOP]). It was found that found that the 
killed B. anthracis AP422ΔuvrAB maintained a highly metabolic 
activity for at least 4 h, showing a state of KBMA. Thus, the 
KBMA strain of B. anthracis AP422ΔuvrAB provided the pro-
spective vaccine candidate strain for anthrax.
Bruhn et al. demonstrated proof-of-concept for a KBMA vac-
cine based on a protozoan pathogen. This approach could be a 
new method for whole-cell vaccination against other complex 
intracellular pathogens. There are currently no effective vaccines 
for visceral leishmaniasis, the second most deadly parasitic infec-
tion in the world. This was a novel whole-cell vaccine approach 
using Leishmania infantum chagasi promastigotes treated with 
the psoralen compound amotosalen (S-59) and low doses of UVA 
radiation. This treatment generated permanent, covalent DNA 
cross-links within parasites and results in Leishmania KBMA. In 
this report, they characterized the in vitro growth characteris-
tics of both KBMA L. major and KBMA L. infantum chagasi. 
Concentrations of S-59 that generated optimally attenuated 
parasites were identified. Like live L. infantum chagasi, KBMA 
L. infantum chagasi parasites were able to initially enter liver 
cells in vivo after intravenous infection. However, whereas live 
L. infantum chagasi infection leads to hepatosplenomegaly in 
mice after 6 mo, KBMA L. infantum chagasi parasites were unde-
tectable in the organs of mice at this time point. In vitro, KBMA 
L. infantum chagasi retained the ability to enter macrophages and 
induce nitric oxide production. These characteristics of KBMA 
L. infantum chagasi correlated with the ability to prophylacti-
cally protect mice via subcutaneous vaccination at levels similar 
to vaccination with live, virulent organisms. Splenocytes from 
mice vaccinated with either live L. infantum chagasi or KBMA 
L. infantum chagasi displayed similar cytokine patterns in vitro. 
These results suggested that KBMA technology is a potentially 
safe and effective novel vaccine strategy against the intracellular 
protozoan L. infantum chagasi.117
Thus several groups have developed recombinant and patho-
gen-derived KBMA vaccine from whole microbes which have 
been shown to be harmless, immunogenic, and correlated with 
disease-specific prevention or reduction in preclinical animal 
models of infectious disease which gives a new hope in this 
direction.
Besides this PUVA has also been used for inactivation of 
diverse other viruses such as dengue virus, Chikungunya virus, 
etc. One of the groups used limes and synthetic psoralens to 
enhance solar disinfection of water. They performed a laboratory 
evaluation with norovirus, E. coli, and MS2. They concluded 
that psoralens and acidic lime extract both interact synergisti-
cally with UV radiation to accelerate inactivation of microbes.118 
Most of the virus inactivation using psoralens has been done 
using platelets. In one of the studies transfusion of platelets was 
done during a Chikungunya virus epidemic in Ile de La Réunion 
that had been prepared with photochemical pathogen inactiva-
tion treatment. It was found that INTERCEPT-CPAs were well 
Figure 4. intercalation of the psoralen molecules between the strands 
of the double-stranded DNa helix or RNa where upon illumination 
with uVc light affects pyrimidines, purines, and flavins, thus promot-
ing the formation of dimmers in RNa (uracil and cytosine) and DNa 
(thymine and cytosine), a process which promotes inactivation of many 
microorganisms.
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Figure 5. List of some of the pS compounds discussed in the manuscript.
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tolerated in a broad range of patients, including infants. The inci-
dence of acute transfusion reactions (ATR) was low and when 
present ATRs were of mild severity.119
B19 is a clinically significant virus that can be transmitted 
through blood transfusion was also inactivated by photochemical 
treatment. It was stated that under defined conditions, photo-
chemical treatment with amotosalen combined with UVA light 
could be used to inactivate B19.120
Amotosalen (S-59) photochemical inactivation of severe acute 
respiratory syndrome coronavirus in human platelet concentrates 
was reported.121 Following photochemical treatment, SARS-CoV 
was consistently inactivated to the limit of detection in seven 
independent APC units. No infectious virus was detected after 
treatment when up to one-third of the APC unit was assayed, 
demonstrating a mean log
10
-reduction of >6.2. Potent inacti-
vation of SARS-CoV therefore extends the capability of the 
INTERCEPT Blood System in inactivating a broad spectrum 
of human pathogens including recently emerging respiratory 
viruses.
A transfusion trial was performed using platelets photochemi-
cally treated for pathogen inactivation using the synthetic pso-
ralen amotosalen HCl.122 Patients with thrombocytopenia were 
randomly assigned to receive either photochemically treated 
or conventional (control) platelets for up to 28 d. Transfusion 
reactions were fewer following photochemically treated platelets 
(3.0% photochemically treated vs. 4.4% control, P = 0.02). The 
incidence of grade 2 bleeding was equivalent for photochemi-
cally treated and conventional platelets, although post-transfu-
sion platelet count increments and days to next transfusion were 
decreased for photochemically treated compared with conven-
tional platelets.
In one of the reports immunogenicity and protective efficacy 
of a psoralen was reported in which dengue-1 virus was inac-
tivated which proved to be a vaccine candidate in Aotus nancy-
maae monkeys. In this experiment the protective efficacy was 
tested of a psoralen-inactivated dengue vaccine candidate in non-
human primates. Psoralen-inactivated DENV-1 was reported to 
be immunogenic in Aotus nancymaae with a reduction in days of 
viremia following experimental challenge.123 Evaluation has also 
been studied in a novel psoralen-inactivated dengue virus type 
1 (DENV-1) vaccine candidate in Mus musculus mice which led 
to the conclusion that psoralen-inactivated DENV-1 is immuno-
genic in mice.124 Poliovirus replication in HeLa cells was reported 
to be significantly inhibited in infected cells with 4,5',8-tri-
methylpsoralen plus long wavelength UV light. When infected 
cells were exposed to psoralen plus light during peak viral RNA 
synthesis, formation of virus-specific RNAs was inhibited. Viral 
RNA species that were either formed in vivo in the presence of or 
treated in vitro with psoralen plus light appeared to have become 
degraded. Treatment with psoralen plus light in vitro resulted in 
the loss of infectivity of single-stranded viral RNA.125
It is known that excessive use of PUVA can cause skin can-
cer.126 There has been concern expressed that psoralens themselves 
may be toxic and/or carcinogenic, but it should be emphasized 
that the use of PUVA to generate vaccines outside the body will 
not pose this risk of carcinogenicity. Indeed, the therapy known 
as extracorporeal photophoresis (treating blood outside the body 
with psoralens and UVA) is widely used for graft-vs-host disease 
and other indications.127
Blue Light Inactivation of Pathogens
The bacterial agents of bioweapons are often chosen from the 
bacteria that show antibiotic resistance or that form endospores 
and biofilms in order to be more resistant against available anti-
bacterial treatment options. It is known that some bacteria can 
be converted into spore forms that may create deadly diseases in 
humans. Early symptoms of anthrax, for instance, can last 1 to 
6 days and resemble the flu, but once the bugs multiply to large 
enough numbers, the body goes into shock and death can occur 
in 24 to 36 h. For these reasons successful phototherapy studies 
against virulent bacteria, fungi, and viruses are needed to defeat 
biological warfare.
UV light killing of bacteria is well understood, but this light-
mediated antimicrobial effect may not be unique, since current 
studies indicate that blue light produces a somewhat similar 
effect. Even when compared with UV irradiation, blue light 
has been accepted to be much less detrimental to mammalian 
cells.128,129 Although effects of blue light seem to vary depending 
on wavelength, dose, and the nature of the bacteria, these wave-
lengths appear to exhibit a broad-spectrum antimicrobial effect 
against both gram-positive and gram-negative bacteria and have 
been suggested as an alternative treatment modality for treating 
some methicillin and penicillin resistance bacterial infections.130
As an example, the 405- and 470-nm blue light showed dose-
dependent bactericidal effects on P. aeruginosa and S. aureus 
in vitro. The results of this study indicated that the fluence of 
5–15 J/cm2 was the optimal dose of blue light for treatment of 
P. aeruginosa while for S. aureus a 470-nm light was used in a 
stronger dose (10–15 J/cm2).36,120,121 High-intensity 405-nm light 
may have application in the medical, military and agricultural 
fields to combat B. anthracis spore exposure which is known 
to have endospores of comparable robustness to B. cereus and 
B. subtilis.41,131,132
The underlying proposed mechanism of action is that light 
may be absorbed by porphyrins produced by bacteria that result 
in increased free radicals, which may affect cytoplasmic mem-
brane proteins and DNA,133 or have a direct effect on photolabile 
pigments in bacteria.134
Further studies support this opinion, indicating existence of 
a therapeutic window of blue light for bacterial infections where 
bacteria are selectively inactivated while host tissue cells are pre-
served.135 Promising outcomes have been achieved when clinical 
trials have been conducted to investigate the use of blue light 
for Helicobacter pylori.136,137 Although the majority of the publica-
tions on the antimicrobial effect of blue light have been confined 
to in vitro studies,138-141 investigation by Dai et al. demonstrate 
potential effects of blue light shown effective in acute, potentially 
lethal P. aeruginosa burn infections in mice.135
As mentioned above, blue light has recently attracted much 
attention in comparison to photodynamic therapy as an alterna-
tive antimicrobial approach142 due to its intrinsic antimicrobial 
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properties without the involvement of added exogenous photo-
sensitizers.130 As a result, the use of blue light inactivation is tech-
nically easier to carry out since the delivery of photosensitizers to 
the target microbes embedded deep within biofilms adherent to 
tissue has been somewhat challenging.
Bacterial spores are capable of extreme resistance to physical 
insults like heat, ionizing, UV and gamma radiation, osmotic 
pressure, and desiccation. The spores also protect the bacteria 
from chemical and biological disinfectants such as iodine, per-
oxides, and alkylating agents.143 High-intensity, nonionizing blue 
light with wavelength of 405 nm and fluence of 1.73 kJ/cm2 is 
capable of inactivate B. cereus, Bacillus megaterium, B. subtilis, 
and Clostridium difficile endospores of 4 log
10
 colony-forming 
units.144
The sporicidal effect of blue light seem to be an oxygen-
dependent process since the efficacy of 405-nm blue light ther-
apy explained by the presence of endogenous photoexcitation of 
intracellular chromophores such as coproporphyrin with Soret 
bands in the 400–420 nm regions of the visible spectrum and the 
subsequent generation of cytotoxic ROS such as singlet oxygen in 
Bacillus and Clostridium bacteria. Blue light can not only regu-
late bacterial motility, suppress biofilm formation, and potentiate 
light inactivation of bacteria, but it may also upregulate bacterial 
virulence factors.145
In spite of the well understood inactivation of pathogenic 
microbial species used in bioweapons with UV light, visible light 
has a clear advantage due to well-recognized risk of UV in skin 
damage and cancer. To what extend UV light can be replaced 
with visible light in pilot studies and clinical application still 
remains questionable, but development of narrow-spectrum illu-
mination of blue light could be lead to some application like air, 
contact surface,146,147 and medical instrument disinfection while 
in the presence of staff and patients which is much more impor-
tant for disinfection of bacterial agents in bioweapons.
In comparison with UV, there is less concern about mutagen-
esis effects of the blue light over mammalian cells since the blue 
light absorption by DNA is weak. Although tissue penetration of 
the blue light is more efficient than UV, several studies have been 
conducted to further increase its penetration depth and make it 
compatible with the less common use of red light in antimicro-
bial PDT for eradication of Gram positive bacteria in vivo. Since 
the microbial cells shows some resistance to UV, one question 
that must be addressed is “Can microbial cells develop resistance 
to blue light inactivation?” To answer this question, the resis-
tance of blue light in microbial cells must be considered.130
Blue light inactivation with some known wavelengths (405, 
415, or 470 nm) revealed antimicrobial effects activity as UV in 
photochemistry studies. For instance blue light with the wave-
length of 405 nm showed strong bacterial killing against gram-
positive and gram-negative bacteria in vitro.148 As a result of this, 
investigation by Enwemeka and colleagues149 has indicated that 
the consecutive delivery of a low light dose was more effective 
than a single high dose. This observation was suggested to be 
verified by in vivo studies.
In another study, inactivation of gram-positive bacteria 
like MRSA with blue light in 405 nm was found to be due to 
photo-stimulation of porphyrin molecule in an oxygen-depen-
dent process.141 Porphyins are different in various bacteria; 
accordingly, slightly different wavelengths may be required to 
be absorbed by various porphyrins. These is no exogenous deliv-
ered photosensitizer involved in inactivation of bacterial using 
blue light which makes it easier to achieve. The wavelength of 
blue light use in infection treatment should be the wavelength 
that selectively absorbed by the chromophore located inside the 
pathogenic microbial cells. This idea further was supported since 
no activity revealed for inactivation of MRSA with blue light 
at 430 nm. Thus use of narrowband filters will provide more 
activity. Although some inactivation was observed at 420 nm, 
the best activity was found at 405 nm. In this wavelength, a blue 
light with absolute dose 23.5 J/cm2 caused 2.4 log
10
 reductions of 
methicillin-resistance S. aureus.150
Enwemeka et al. in another study138 worked with two differ-
ent strains of S. aureus: MRSA US-300 (strain of CA-MRSA) 
and IS853 (strain of HA-MRSA) in vitro with different wave-
length of blue light. The results showed that various wavelength 
produced a statistically significant dose-dependent reduction in 
both strains. However, maximum eradication of the CA-MRSA 
was achieved in 405 nm and HA-MRSA in 470 nm of blue light 
with 10 min irradiation. The eradication levels increased with 
increasing the light dose, albeit not linearly. The conclusion of 
the study was that phototherapy with low dose blue light may be 
an effective clinical tool for MRSA infections.
Blue light studies with the wavelength of 415 ± 10 nm in a 
mouse skin abrasion model infected with hospital-acquired 
MRSA was highly successful135 and results in terms of log-reduc-
tion was more effective than that using bacterial suspensions in 
vitro. As found in this study, the required light fluence was 10- to 
100-fold less than the light dose exposure needed for the equiva-
lent bacterial inactivation in vitro.151-153 One possible mechanism 
for this surprising finding would be that the metabolism of bac-
terial cells in vivo favored blue-light inactivation compared with 
broth cultured cells. Possibly in vivo growth promoted the bio-
synthesis of intracellular porphyrins, thus making the microbial 
cells in the tissue more sensitive to blue light than the identical 
cells growing in liquid growth medium.
The amount of light energy needed to kill biofilm154 and 
endospores144 is 10-fold higher than that needed to kill vegeta-
tive B. cereus and C. difficile cells; therefore, a blue light source 
with higher intensity is one important aspect of phototherapy. 
The efficacy of blue light is dependent on the wavelength, the 
irradiance, the duration of exposure, and the exposed body sur-
face area. The phototherapy devices should not produce a lot of 
heat and should have a stable broad wavelength light output. 
Therefore, LED with greater efficacy and higher irradiance can 
be an ideal light source for the phototherapy.
A high intensity prototype blue gallium nitride LED photo-
therapy unit has been developed and its efficacy compared with 
commercially used phototherapy device by measuring both in 
vitro and in vivo bilirubin photodegradation.155 In this study 
microhematocrit tubes (44 ± 7% vs. 35 ± 2%) were used for in 
vitro experiments and for in vivo experiments Gunn rats (30 ± 
9% vs. 16 ± 8%) were applied. The LED device with two focused 
814 Virulence Volume 4 issue 8
arrays, each with 500 blue LEDs, showed a significantly higher 
efficacy of bilirubin photodegradation than the conventional 
phototherapy in both in vitro and in vivo experiment.
Photodynamic Inactivation (PDI)  
of Biological Warfare Agents
Photodynamic therapy (PDT) is a non-invasive procedure 
that uses a non-toxic photosensitizer (PS) and harmless visible 
or near-infrared (NIR) light to generate singlet oxygen and other 
reactive oxygen species (ROS) that react with biomolecules such 
as nucleic acids, proteins, and unsaturated lipids. In applications 
of PDT aimed at, for instance, curing cancer, the ROS cause 
damage to these crucial biomolecules within the tumor cells and 
initiate apoptosis leading to cell death. However, these previously 
referred to biomolecular targets of PDT (proteins, lipids, nucleic 
acids) are also major constituents of all the classes of biowarfare 
agents listed above. Hence PDT can destroy all known biowar-
fare agents.
This desirable property of destroying all classes of pathogen is 
not totally unique to PDT; certain other strong oxidizing agents 
such as boiling peracetic acid, chlorine dioxide, and cross-linking 
agents such as glutaraldehyde will also accomplish this feat. It 
is known that UV radiation and ionizing radiation will destroy 
bacteria, fungi, spores, and viruses, but not toxins. However, we 
believe that PDT has the potential to be the most versatile and 
certainly the most biocompatible strategy to combat biowarfare 
agents no matter if they are bacteria, viruses, fungi, spores, or 
even toxins.
PDT using the appropriate choice of photosensitizer and light 
could be used to destroy pathogens in water, on surfaces such as 
vehicles and equipment, in food, on skin, in wounds, and even 
when the agents have established localized infections in humans 
before systemic invasion has occurred. One important consider-
ation in using PDT to decontaminate large surfaces (housing or 
vehicles) is that the PS can be efficiently activated by sunlight 
and after destroying all the microorganisms the residual PS will 
be harmlessly photobleached, and therefore would be considered 
environmentally friendly compared with alternative disinfec-
tants. An additional advantage of PDT is its high level of selec-
tivity, achieved through PS that selectively target specific cells or 
tissue types and the ability to control the illumination area.
Since mid-1990s, antimicrobial photodynamic-inactivation 
(PDI) and therapy has been developed as a prolific discovery and 
development platform, exploring many aspects of the microbial 
phenotype related to multidrug resistance such as efflux systems, 
biofilms, bacterial spores, and virulence determinants.152
Bacteria
In the 1990s, it was observed that there was a fundamental 
difference in susceptibility to PDT between gram-positive and 
gram-negative bacteria. It was found that, in general, neutral 
or anionic PS molecules are efficiently bound to and photody-
namically inactivate gram-positive bacteria, whereas they are 
bound, to a greater or lesser extent, only to the outer membrane 
of gram-negative bacterial cells but do not inactivate them after 
illumination.156 In order to inactivate gram-negative bacteria it is 
necessary to use PS with pronounced cationic charge or to take 
other measures to permeabilize the gram-negative cell wall.157 
The high susceptibility of gram-positive species is explained by 
their physiology, as their cytoplasmic membrane is surrounded 
by a relatively porous layer of peptidoglycan and lipoteichoic acid 
that allows PS to cross.156,158 The cell envelope of gram-negative 
bacteria consists of an inner cytoplasmic membrane and an outer 
membrane that are separated by the peptidoglycan-containing 
periplasm. The outer membrane forms a physical and functional 
barrier between the cell and its environment. In the outer mem-
brane, several different proteins are present. Some of them func-
tion as pores to allow passage of nutrients, whereas others have an 
enzymatic function or are involved in maintaining the structural 
integrity of the outer membrane and the shape of the bacteria.159
MRSA infections kill 19 000 hospitalized American patients 
annually; equivalent to the combined number of deaths due to 
AIDS, tuberculosis, and viral hepatitis.160 In general, MRSA 
virulence factors are similar to those of S. aureus, with certain 
MRSA strains appearing to contain particular genetic back-
grounds or factors that enhance their virulence and enabling par-
ticular clinical syndromes with net effect of creating havoc in the 
affected communities161-164 (Fig. 6). There have been several pre-
vious reports on PDI of MRSA finding the drug-resistant strain 
to be as sensitive as the naïve strain165 or be slightly less sensitive 
when compared with wild-type strains.166 However, during the 
last few years, MRSA resistance has increased due to constant use 
of antimicrobials.167
During PDI, PDT combined with photosensitizer (PS) tolu-
idine blue O (TBO) (Fig. 5I), scientist were able to eliminate 
100% of the MRSA in a sample obtained from a human wound 
with 3 laser exposures of 15 min duration.168 Aluminum disulfo-
nated phthalocyanine (AlPcS2) (Fig. 5B) was able to kill 3 logs of 
MRSA after gallium arsenide laser illumination (1.2 J, 11 mW) 
regardless the grow phase and the presence of horse or human 
serum as the medium.169,170 Tetrapyrrole-based photosensitizers, 
such as the porphyrin XF-73 (Fig. 5D) and the phthalocyanine 
RLP068/Cl (Fig. 5F), can kill multiple logs of MRSA respec-
tively.171,172 In the same experimental conditions RLP068/Cl (but 
not TBO) was able to kill MRSA.173 Sixteen epidemic strains 
of MRSA were subjected to PDI with AIPcS2 and all of them 
were susceptible to killing in a PS concentration-dependent man-
ner.174 PDI is effective in MRSA even when carried with non-
coherent red light and polyethylenimine (PEI)-ce6 (2.7 logs of 
killing)175 and is useful in wound models.176 Treatment of local 
MRSA infections was improved when Hematoporphyrin (Hp) 
was encapsulated in liposomes or micelles.177
S. pyogenes, also known as in group A streptococcus (GAS or 
group A strep), has been estimated to cause more than 500 000 
deaths every year, making it one of the most harmful pathogens 
in the world.178 Lethal photosensitization of S. pyogenes was per-
formed with Indocyanine green (Fig. 5J), a negatively-charged 
polymethine dye, and a gallium–aluminum–arsenide (Ga–
Al–As) NIR-Laser. Killing was 6.8 log, and even at the lowest 
concentration (25 μg/ml) killing was 4.7 log (99.99%).179 PDI 
can be enhanced by PS entrapping.177 A major difficulty in the 
inactivation of S. pyogenes is the formation of biofilms which are 
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much more resistant to drug attack than isolated form of these 
bacteria. Hope and Wilson performed an interesting experiment 
which evaluated real-time PDI of S. pyogenes biofilms. They used 
Sn (IV) chlorin e6 (SnCe6) (Fig. 5L) as PS and illuminated with 
488 nm argon and 543 nm HeNe lasers in a confocal micro-
scope. Scanning the biofilm three times for 5 min each, they 
obtained significant reduction in biofilm fluorescence indicating 
the inactivation of the biofilm.180
The gram-negative bacteria Brucella abortus and F. tularen-
sis are responsible for extremely dangerous infections, brucello-
sis and tularaemia, respectively and are considered two of the 
most likely biowarfare agents. Both bacteria, in suspension with 
0.1 mL of diluted methylene blue (MB) (Fig. 5E), with concen-
tration 5 to 500 ppm were inactivated when illuminated with 
a 650 nm LED.181 B. abortus and F. tularensis were illuminated 
with 650 nm LED and saline and no killing effect was observed 
eliminating the possibility of photothermal damage.181
Recently, Y. pestis, a gram-negative bacterium, has gained 
attention as a possible biological warfare agent. A possible sur-
rogate to study photoinactivation of Y. pestis is the gram-negative 
bacterium Y. enterocolitica. Using MB and several of its congeners 
against Y. enterocolitica, with illumination using a lamp emitting 
light in the waveband 615–645 nm, considerable bactericidal 
activity was noted using similar photosensitizer concentrations 
to those used elsewhere to inactivate blood-borne viruses. Two 
novel compounds in this area, the phenothiazinium new methy-
lene blue N (Fig. 5M) and the phenoxazinium Brilliant Cresyl 
Blue (Fig. 5N) exhibited bactericidal activity at lower concentra-
tions than both of the established phenothiaziniums, MB and 
TBO and the recently published blood photovirucidal agent 
1,9-dimethyl methylene blue (Fig. 5G). The photoactivity of 
these compounds was undiminished in the presence of red blood 
cells.182
Macrophages are immune cells that play a pivotal role in the 
detection and elimination of pathogenic microorganisms by 
phagocytosis. Numerous pathogens, such as species of Francisella, 
Legionella, Brucella, and Yersinia pestis, parasitize macrophages, 
utilizing them as a host cell for their growth and replication, 
sometimes with disastrous effects. These infected macrophages 
therefore are a prime target for therapy and macrophage-targeted 
PDT may have a role to play especially when the infected macro-
phages are present in a localized granuloma.183
Bacterial infections
Because PDI can have high selectivity for bacterial cells com-
pared with host mammalian cells it is particularly suited as a 
treatment for localized infections.159,184 The PS is topically applied 
into the infected tissue which is then illuminated after a relatively 
short incubation time to ensure the PS is bound to the bacteria but 
has not had time to gain access to the host cells. The advantages 
of this approach compared with traditional antibiotics include 
its broad spectrum, rapid action, its equal effectiveness against 
multiply drug-resistant bacteria, and its ability to destroy bacteria 
in damaged tissue that has compromised blood perfusion. The 
effectiveness of PDI mediated by many of the PS described above 
Figure 6. pathogenic factors of S. aureus, showing both the structural and the secreted products, playing roles as virulence factors. (A) Surface and 
secreted proteins; (B and C) are cross-sections of the cell envelope, from references 162 and 244 with modifications.
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has been demonstrated in mouse models of wound infections 
(E. coli,185 P. aeruginosa,186 Vibrio vulnificus,187 and MRSA151). 
PDI has also been studied in models of third degree burn infec-
tions by S. aureus188 and A. baumannii.189,190 The effectiveness of 
PDI has also been demonstrated in deep established soft tissue 
abscesses caused by S. aureus.191
Bacterial endopores
B. anthracis is a gram-positive, endospore-forming bacterium 
that can grow under aerobic or anaerobic conditions. It is one of 
the major security and bioterrorism threats for this century since 
it cannot be easily inactivated by heat, radiation, antibiotics, or 
other antimicrobial agents.192 The experimental study of PDI of 
B. anthracis is difficult because of the biohazard risk involved.193 
Inhalation or ingestion will then cause a serious and frequently 
fatal disease, while entry of the spores into cuts and abrasions on 
the skin produces a less fatal but still serious disease, cutaneous 
anthrax. Anthrax is particularly deadly to humans due to the bac-
terium’s ability to produce toxins with a sophisticated mechanism 
for killing mammalian cells.194 Demidova and Hamblin195 pub-
lished a study demonstrating that a class of small cationic dyes 
known as phenothiazinium salts could photoinactivate 4 species 
of Bacillus spores that are surrogates to B. anthracis,196 includ-
ing B. cereus and B. thuringiensis, which are the same species as 
B. anthracis.197 There were large differences in susceptibility to 
TBO-mediated PDI between spores of different Bacillus species. 
Spores of B. cereus and B. thuringiensis were the most suscep-
tible. TBO (50 μM) demonstrated a light-dose-dependent loss of 
viability of B. cereus and B. thuringiensis spores, with 40 J/cm2 of 
630 nm light leading to 99.999% killing. In contrast, B. subtilis 
and B. atrophaeus were much less sensitive and needed concentra-
tions as high as 1.6 mM to achieve killing of >99.9% of cells and 
B. megaterium.195 The relatively mild conditions needed for spore 
killing could have applications for treating wounds contaminated 
by anthrax spores, for which conventional sporicides would have 
unacceptable tissue toxicity.195
Oliveira et al.198 demonstrated that B. cereus endospores could 
be inactivated by porphyrin PS and light. There was a much 
smaller difference in sensitivity between spores and vegetative 
cells of B. cereus (the TBO concentration needed to kill spores 
was 3 to 4 times higher than that needed to kill vegetative cells) 
than between spores and vegetative cells of B. subtilis (>100 times 
the TBO concentration was needed to kill spores compared with 
vegetative cells).195
B. atrophaeus has been used as a simulant for the biologi-
cal warfare agent B. anthracis for decades. PDI of these spores 
was possible using an intense pulsed (period of 100 ms) visible 
light source in association with TMPyP (5, 10, 15, 20-Tetrakis 
[1-methylpyridinium-4-yl]-porphyrin tetra p-toluenesulfonate) 
(Fig. 5K). PDI induced oxidative damage which killed up to 
6 log (>99.9999%) within a total treatment time of 10 s (fluencies 
from 20 J/cm2 up to 80 J/cm2) using a TMPyP in a concentra-
tion range of 1–100 μmol.199 Similar experiment performed with 
only a single light flash (10 or 20 J/cm2) and 10 μmol of TMPyP 
was able to kill more than 4 log of B. atrophaeus.200 These studies 
reinforce the application of PDI in military and national security 
for decontamination of anthrax spores.198
Fungi
Fungi are eukaryotic cells that possess a cell wall outside the 
plasma membrane. Coccidioides immitis is the only fungal spe-
cies present on the Select Agents Appendix A (biological warfare 
agents)201: it is dimorphic, producing a mycelial form in nature 
that ages to produce spores (arthroconidia) that separate in a 
characteristic fashion via the disarticulation of the parent myce-
lium leaving the ruptured cell-wall fragments of adjacent cell 
remnants attached to opposing ends (Fig. 7). In vivo the spores 
enlarge to form spherules that are typically 20 microns or more 
in diameter when viewed in tissue sections of actively infected 
hosts. The spherules undergo internal divisions to yield endo-
spores that are released upon maturation and go on to repeat the 
cycle of the infection.202 Infection of normal hosts with spores of 
C. immitis can result in a spectrum of consequences ranging from 
minimal symptoms of disease or it can establish an active repli-
cating cycle that can include profound pulmonary disease and 
dissemination from the pulmonary focus via the bloodstream to 
involve multiple systems of the body (typically meningitis, skin, 
bone, and internal organs). There are literature reports of PDI of 
a few species of fungus including both yeasts (Saccharomyces203 
and Candida spp.204, 205) and filamentous fungi (Trichophyton206 
and Aspergillus207). As yet there have been no reports of PDT 
on actual C. immitis organisms but the successful eradication 
of related fungal species suggests that PDT should work well 
against this pathogen. Junqueira et al.208 reported on the use of 
a cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-
29H, 31H-phthalocyanine (Fig. 5C) to mediate PDI of biofilms 
formed by Candida spp. and the emerging pathogens Trichosporon 
mucoides and Kodamaea ohmeri.
Viruses
The short-lived ROS generated by PDI mechanisms are 
responsible for the damage induced to critical molecular targets 
in viruses.209,210 Different viral targets, such as the envelope lip-
ids and proteins, capsid and core proteins, and the nucleic acid, 
can be attacked by singlet oxygen and/or other ROS (hydrogen 
peroxide, superoxide, and hydroxyl radicals) to achieve the loss 
of infectivity.210 Viral DNA is one of the critical target structures 
for PDI by MB and light MB causing direct DNA damage and 
blockage of DNA replication which has been successfully used 
for HSV-1 treatment.211 It has been shown that enveloped viruses 
can be inactivated due to protein damage. However, while the 
same treatment is reported to be ineffective against some non-
enveloped viruses,212 the results from Wong et al.213 showed that 
even a non-enveloped virus can be efficiently inactivated due to 
the damage induced by PDI to its viral proteins. The efficiency 
of different types of PS in viral PDI has been proved for dif-
ferent types of mammalian viruses and bacteriophages, whether 
they are enveloped or non-enveloped, for either DNA or RNA 
viruses.214 PDI of viruses has been of special interest for applica-
tions in blood banking sterilization.215 Therefore, several types of 
virus have been tested for PDI.215
Ebola
The filoviruses, Marburg and Ebola, are classified as Category 
A biowarfare agents by the Centers for Disease Control. Most 
known human infections with these viruses have been fatal 
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(fatality rates for humans of up to 
90%) and no vaccines or effective 
therapies are currently available. 
They are enveloped, nonsegmented, 
negative-stranded RNA viruses.216 
Enveloped, RNA viruses from 
two different families, Semliki 
Forest virus (SFV, Togaviridae) and 
vesicular stomatitis virus (VSV, 
Rhabdoviridae), and can act as surro-
gate filovirus models for PDI. Using 
a suspension of 1 mg/ml fullerene 
C60 (buckyball) (Fig. 5O) as the 
PS and visible light (wavelengths 
higher than 495 nm) under constant 
stirring and flushing with oxygen, 
values of 7 log reduction for 5 h of 
illumination were obtained for both 
families of enveloped virus.217 VSV 
plaque forming units were decreased 
by 5 log using methoxy-polyethylene 
glycol conjugated fullerene, illumi-
nated by 120 J/cm2 white light.218
Smallpox: Variola major and 
Variola minor (Orthopoxviruses).
It is known that smallpox has been used as a biowarfare agent 
in the past. During World War II, scientists from the United 
Kingdom, the United States, and Japan were involved in research 
into producing a biological weapon from smallpox.219 In 1992 
Soviet defector Ken Alibek confirmed that the Soviet bioweapons 
program at Zagorsk had produced a large stockpile—as much 
as 20 tons—of weaponized smallpox (possibly engineered to 
resist vaccines), along with refrigerated warheads to deliver it. It 
is not known whether these stockpiles still exist in Russia. With 
the breakup of the Soviet Union and unemployment of many 
of the weapons program’s scientists, there is concern that small-
pox and the expertise to weaponize it may have become available 
to other governments or terrorist groups who might wish to use 
virus as means of biological warfare.220 The last occurrence of 
endemic smallpox was in Somalia in 1977, and the last human 
cases were laboratory-acquired infections in 1978. There are four 
types of Variola major smallpox: ordinary (the most frequent 
type, accounting for 90% or more of cases); modified (mild and 
occurring in previously vaccinated persons); flat; and hemor-
rhagic (both rare and very severe). Historically, Variola major has 
an overall fatality rate of about 30%; however, flat and hemor-
rhagic smallpox are usually fatal. Present laboratory examination 
of Variola virus requires high-containment (Biosafety Level 4).221
Variola virus is the most notorious poxvirus, a member of a 
family of large, enveloped DNA viruses. It is generally accepted 
that enveloped viruses can be inactivated efficiently by singlet 
oxygen generating agents such as PDI. PDI of HIV-1 by MB/
light treatment acts on HIV-1 at different target sites: the enve-
lope and core proteins, and the inner core structures like RNA.222
Four PS (MB, rose bengal [RB] [Fig. 5H], uroporphyrin [UP], 
and aluminum phthalocynine tetrasulphonate [AlPcS4]) could 
inactivate adenovirus. Using MB (2.7 mM) and light (intensity 
of 106 mW/cm2) produced a complete inactivation of adenovirus 
after 1 min of exposure: 10 mM of RB was enough for just 0.5 log 
reduction after 20 min of illumination and complete inactivation 
was obtained after 30 min PDI with UP; however, AlPcS4 could 
not completely inactivate adenovirus even when used in 50 mM 
for 30 min.223
Nucleic acids may be important targets for photoinactiva-
tion of DNA viruses by MB and AlPcS4.224 Photoinactivation of 
DNA viruses are more efficiently induced by free than by DNA 
bound porphyrin. Photoreactions of TMPyP and TMPyMPP 
affect the structural integrity of DNA and also of viral proteins, 
despite their selective DNA binding.225 The binding of cationic 
porphyrins to DNA is presumably due to the electrostatic inter-
action between the positively-charged substituents in the por-
phyrin macrocycle and the negatively charged phosphate oxygen 
atoms of DNA.226
Lassa virus (Arenavirus) and RVF virus (Bunyaviridae)
Lassa virus (LASV) is an Arenavirus that causes Lassa hemor-
rhagic fever in human and non-human primates. Rift Valley fever 
(RVF) is caused by RVF virus belonging to Bunyaviridae, which 
is a family of negative-stranded, enveloped RNA viruses. Lassa 
virus and RVF virus are enveloped RNA viruses that are select 
agents requiring Biosafety Level 4-equivalent containment.221
Dengue virus
Dengue and yellow fever viruses belong to the genus Flavivirus 
single-stranded RNA viruses. Dengue virus, an enveloped RNA 
virus, could be inactivated using MB in combination with a LED 
cluster (mid-peak bandwidth 29 nm, peak 664 nm). The amount 
of dengue virus reaming was evaluated by plaque forming assays. 
Dengue virus was completely inactivated within 5 min when the 
Figure 7. Coccidiodes immitis is the only fungal species present on the Select agents appendix a (biologi-
cal warfare agents).201 it is dimorphic, producing a mycelial form in nature that matures to produce spores 
(arthroconidia) that go on to repeat the cycle of the infection.202
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MB concentration was higher than 1.0 μg/mL.227 Lin et al.228 
compared light-dependent and light independent inactivation of 
dengue-2 and other enveloped viruses by the two regio-isomers of 
carboxyfullerene and found that asymmetric isomer had greater 
dark activity (even at much higher concentrations than needed 
for its PDT effect) due to its interaction with the lipid envelope 
of the virus.
Toxins
PDI is one of the few antimicrobial treatments that is also 
capable of inactivating toxins and secreted virulence factors pro-
duced by pathogens. The reactive oxygen species produced dur-
ing photodynamic action (1O
2
 and HO•) can attack molecular 
features susceptible to oxidation (sulfur atoms, aromatic rings, 
heterocyclic rings, unsaturated double bonds, amino groups, etc.) 
present on the toxin molecules themselves. These oxidative reac-
tions can disturb the conformation or alter the functional groups 
of the toxins and abolish the biological function (Fig. 8). This 
approach has been well-demonstrated in the case of lipopolysac-
charide (LPS, endotoxin from gram-negative bacteria). Komerik 
et al.229 first showed that TBO and red light could inactivate LPS 
from E. coli and they also were able to inactivate proteases from 
P. aeruginosa. Gianelli and colleagues230 used MB combined 
with various light sources to inac-
tivate P. gingivalis LPS adherent to 
titanium discs, cut from commercial 
dental implants. Tubby et al.231 stud-
ied the ability of MB and red light 
to inactivate the following secreted 
virulence factors of S. aureus: V8 
protease, α-hemolysin, and sphingo-
myelinase were shown to be inhib-
ited in a dose-dependent manner by 
exposure to light in the presence of 
MB. Eubanks et al.232 showed that 
an actual biowarfare agent, botuli-
num neurotoxin, could be photoin-
activated by exposure to riboflavin 
and white light. Our laboratory has 
obtained evidence that two addi-
tional microbial toxins, Shiga-like 
toxin from E. coli O157 and myco-
lactone from Mycobacterium ulcerans 
can be destroyed by exposure to ben-
zoporphyrin derivative and red light 
(manuscript in preparation).
Anti-Microbial Effect of 
Femtosecond Lasers
It has been proposed that femto-
second lasers, or lasers that maintain 
a pulse duration of 10−15 s, break 
down transparent or semitranspar-
ent biological tissues due to nonlin-
ear absorption of laser energy with 
minimal thermal and mechanical 
effects.233 As a result of the adverse collateral damage possible 
with other laser systems, the femtosecond laser has been hypoth-
esized to be a new approach for killing pathogens.
Recently, a series of studies reported the efficacy of a visible 
femtosecond laser or a near-infrared subpicosecond fiber laser on 
inactivation of a variety of viral species, including M13 bacterio-
phage, tobacco mosaic virus, human papillomavirus, and human 
immunodefficiency virus.234-240 M13 phages were inactivated by 
using a very low power (as low as 0.5 nJ/pulse) visible femtosec-
ond laser with 425 nm wavelength, 100 fs pulse width, power 
density ≥ 50 MW/cm2 237.
One group reported241 inactivation of an encephalomyocar-
ditis virus, M13 bacteriophage, and Salmonella Typhimurium 
by a visible femtosecond diode-pumped continuous-wave (CW) 
mode-locked Ti-sapphire laser. The laser produced a continu-
ous train of 60 fs pulses at a repetition rate of 80 MHz. The 
excitation laser was chosen to operate at a wavelength of λ = 
425 nm and with an average power of about 50 mW. It has a 
pulse width of full-width at half maximum (FWHM) ≅ 100 fs. 
All the microorganisms were inactivated very efficiently, espe-
cially S. Typhimurium. There were different mechanisms of 
inactivation of different microorganism by femtosecond laser. 
Figure  8. Diagrammatic representation of the mode of action of several bacterial toxins. (A) Damage 
to cellular membranes by Staphylococcus aureus toxin. after binding and oligomerization, the stem of 
the mushroom-shaped toxin heptamer inserts into the target cell and disrupts membrane permeability 
as depicted by the influx and efflux of ions represented by red and green circles. (B) inhibition of pro-
tein synthesis by Shiga toxins (Stx). Holotoxin, which consists of an enzymatically active (A) subunit and 
5 binding (B) subunits, enters cells through the globotriasylceramide (Gb3) receptor. The N-glycosidase 
activity of the (A) subunit then cleaves an adenosine residue from 28S rRNa, which halts protein synthe-
sis. (C) examples of bacterial toxins that activate secondary messenger pathways. Binding of the heat-
stable enterotoxins (ST) to a guanylate cyclase receptor results in an increase in cyclic GMp (cGMp) that 
adversely effects electrolyte flux. By aDp-ribosylation or glucosylation respectively, the c3 exoenzyme 
(c3) of Clostridium botulinum and the Clostridium difficile toxins a and B (cda and cdB) inactivate the small 
Rho GTp-binding proteins. cytotoxic necrotizing factor (cNF) of E. coli and the dermonecrotic toxin (DNT) 
of Bordetella species activate Rho by deamidation.
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Inactivation of viruses involves the breaking of hydrogen/hydro-
phobic bonds or the separation of the weak protein links in the 
protein shell of a viral particle. On the contrary, inactivation of 
bacteria is related to the damage of their DNA due to irradiation 
of a visible femtosecond laser.
Another study242 reported the inactivation of murine cytomeg-
alovirus (MCMV), an enveloped, double-stranded DNA virus, 
by a visible (425 nm) femtosecond laser. The results showed that 
the laser irradiation caused a 5-log reduction in MCMV titer and 
caused selective aggregation of viral capsid and tegument pro-
teins. However, the femtosecond laser did not cause significant 
changes to the global structure of MCMV virions including 
membrane and capsid, as assessed by electron microscopy; mean-
while, it could not produce the double-strand breaks or crosslink-
ing in MCMV genomic DNA.
Manipulation of a near-infrared (NIR) femtosecond laser via 
impulsive stimulated raman scattering (ISRS) to produce dam-
age (e.g., to the protein coat of a virus) is another method for 
selectively inactivating microorganisms.237
When NIR femtosecond laser induced the inaction of virus 
and bacteria, its safety to the mammalian cells was considered. 
The relative research demonstrated that if the wavelength and 
pulse width of the femtosecond laser were appropriately selected, 
there was a window in power density that enabled them to 
achieve selective inactivation of target viruses and bacteria with-
out causing cytotoxicity to mammalian cells. It was suggested 
that this strategy targeted the mechanical (vibrational) properties 
of microorganisms and thus its antimicrobial efficacy was likely 
to be unaffected by genetic differences in the microorganisms.238
In the view of the emerging threats from drug resistant patho-
gens and microorganisms, developing novel and more effective 
antimicrobial strategies is an absolute necessity. One such strat-
egy is to develop the ultrashort pulsed (USP) laser technology as 
an effective and chemicals free inactivation technique that can be 
successfully used over broad spectrum of pathogens, both from 
bacterial and viral sources.243
In summary, the advantages of such novel laser technologies 
over the presently prevailing disinfection methods include: they 
are considered as noninvasive disinfection technologies, because 
no foreign materials are needed in the disinfection process; 
they are harmless environmental disinfection methods since no 
chemicals are used in the pathogen inactivation process; and they 
are general methods for selective disinfection of pathogens with 
potentially minimal side effects.241
Conclusion
Recent studies have highlighted the diversity of applications of 
light-mediated technology against pathogens of all known classes. 
Wavelengths from the short-UV to the near-infrared (either alone 
or combined with PS) can be used to kill or inactivate gram-
positive and gram-negative bacteria, fungi, endospores, para-
sites, viruses, and even protein toxins. The mechanisms of action 
depend on the different microbial types and the wavelength and 
presence or not of a PS. The two broad target classes are nucleic 
acids for UVC and PUVA and oxidizable proteins for photocatal-
ysis, PDT, and blue light. The broad occurrence of these biologi-
cal targets in bioweapons agents means that the light-mediated 
technology is highly likely to be very broad-spectrum, thus avoid-
ing the need to know the identity of the particular agent in any 
mass biological attack, and also suggests that the development of 
resistance to light-mediated inactivation is likely to non-existent. 
Furthermore, light is non-polluting and environmentally friendly, 
and even if PS need to be used, these compounds are likely to be 
photodegraded rapidly when the bio-threat has been neutralized 
thus leaving no lasting pollution. The use of light-based technol-
ogy to prevent and treat actual infections suggests that they may 
be useful to decontaminate humans that have already received 
exposure to biological agents, without causing undue harm to 
host tissue. Lastly light-based inactivation may be particularly 
suitable to form vaccines as they kill pathogens while preserving 
their antigenicity.
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